Amedeo Smart

Free Medical Literature Service


 

Amedeo

Dermatology

  Free Subscription

Articles published in
Int J Cancer
    September 2021
  1. VAN ZEIJL MCT, van den Eertwegh AJM, Wouters MWJM, de Wreede LC, et al
    Discontinuation of anti-PD-1 monotherapy in advanced melanoma - outcomes of daily clinical practice.
    Int J Cancer. 2021 Sep 14. doi: 10.1002/ijc.33800.
    >> Share

    August 2021
  2. TANIGUCHI H, Natori Y, Miyagi Y, Hayashi K, et al
    Treatment of primary and metastatic breast and pancreatic tumors upon intravenous delivery of a PRDM14-specific chimeric siRNA/nanocarrier complex.
    Int J Cancer. 2021;149:646-656.
    >> Share

    July 2021
  3. KOSTOS L, Hong W, Lee B, Tran B, et al
    Cancer clinical trial vs real-world outcomes for standard of care first-line treatment in the advanced disease setting.
    Int J Cancer. 2021;149:409-419.
    >> Share

  4. CHA C, Ahn SG, Kim D, Lee J, et al
    Axillary response according to neoadjuvant single or dual human epidermal growth factor receptor 2 (HER2) blockade in clinically node-positive, HER2-positive breast cancer.
    Int J Cancer. 2021 Jul 2. doi: 10.1002/ijc.33726.
    >> Share

  5. DARLIX A, Hirtz C, Mollevi C, Ginestet N, et al
    Serum GFAP is a predictor of brain metastases in patients with metastatic breast cancer.
    Int J Cancer. 2021 Jul 1. doi: 10.1002/ijc.33724.
    >> Share

  6. EISSA IR, Mukoyama N, Abdelmoneim M, Naoe Y, et al
    Oncolytic herpes simplex virus HF10 (canerpaturev) promotes accumulation of CD8(+) PD-1(-) tumor-infiltrating T cells in PD-L1-enriched tumor microenvironment.
    Int J Cancer. 2021;149:214-227.
    >> Share

    June 2021
  7. BUDUKH A, Dikshit R, Chaturvedi P
    Outcome of the randomized control screening trials on Oral, Cervix and Breast Cancer from India and way forward in COVID-19 pandemic situation.
    Int J Cancer. 2021 Jun 21. doi: 10.1002/ijc.33712.
    >> Share

  8. ISHEDEN G, Grassmann F, Czene K, Humphreys K, et al
    Lymph node metastases in breast cancer: investigating associations with tumor characteristics, molecular subtypes, and polygenic risk score using a continuous growth model.
    Int J Cancer. 2021 Jun 7. doi: 10.1002/ijc.33704.
    >> Share

    May 2021
  9. HAGENAARS SC, de Groot S, Cohen D, Dekker TJA, et al
    Tumor-stroma ratio is associated with Miller-Payne score and pathological response to neoadjuvant chemotherapy in HER2-negative early breast cancer.
    Int J Cancer. 2021 May 27. doi: 10.1002/ijc.33700.
    >> Share

  10. ALSENDI M, O'Reilly D, Zeidan YH, Kelly CM, et al
    Oligometastatic Breast Cancer: Are We There Yet?
    Int J Cancer. 2021 May 20. doi: 10.1002/ijc.33693.
    >> Share

  11. WU AH, Franke AA, Wilkens LR, Tseng C, et al
    Risk of Breast Cancer and pre-diagnostic urinary excretion of bisphenol A, triclosan, and parabens: the Multiethnic Cohort Study.
    Int J Cancer. 2021 May 20. doi: 10.1002/ijc.33692.
    >> Share

  12. ARROYO MUHR LS, Hultin E, Dillner J
    Transcription of Human Papillomaviruses in Non-Melanoma Skin Cancers of the Immunosuppressed.
    Int J Cancer. 2021 May 14. doi: 10.1002/ijc.33683.
    >> Share

  13. LILLEBORGE M, Falk RS, Sorlie T, Ursin G, et al
    Can breast cancer be stopped? Modifiable risk factors of breast cancer among women with a prior benign or premalignant lesion.
    Int J Cancer. 2021 May 14. doi: 10.1002/ijc.33680.
    >> Share

    April 2021
  14. BRANE A, Behring M, Halilova KI, Norian L, et al
    Comments on "Association between breast cancer risk and disease aggressiveness: Characterizing underlying gene expression patterns".
    Int J Cancer. 2021 Apr 22. doi: 10.1002/ijc.33605.
    >> Share

  15. SUN Q, Novak D, Huser L, Poelchen J, et al
    FOXD1 Promotes Dedifferentiation and Targeted Therapy Resistance in Melanoma by Regulating the Expression of CTGF.
    Int J Cancer. 2021 Apr 9. doi: 10.1002/ijc.33591.
    >> Share

  16. CHRISTAKOUDI S, Pagoni P, Ferrari P, Cross AJ, et al
    Weight change in middle adulthood and risk of cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
    Int J Cancer. 2021;148:1637-1651.
    >> Share

    March 2021
  17. PARK YM, Shivappa N, Petimar J, Hodgson ME, et al
    Dietary inflammatory potential, oxidative balance score, and risk of breast cancer: findings from the Sister Study.
    Int J Cancer. 2021 Mar 30. doi: 10.1002/ijc.33581.
    >> Share

  18. INDUKURI R, Jafferali MH, Song D, Damdimopoulos A, et al
    Genome-Wide Estrogen Receptor beta Chromatin Binding in Human Colon Cancer Cells Reveals its Tumor Suppressor Activity.
    Int J Cancer. 2021 Mar 22. doi: 10.1002/ijc.33573.
    >> Share

  19. KOCH T, Jorgensen JT, Christensen J, Dehlendorff C, et al
    Breast Cancer Rate after Oophorectomy: A Prospective Danish Cohort Study.
    Int J Cancer. 2021 Mar 17. doi: 10.1002/ijc.33563.
    >> Share

  20. SONNENBLICK A, Agbor-Tarh D, de Azambuja E, Hultsch S, et al
    STAT3 activation in HER2-positive breast cancers: Analysis of data from a large prospective trial.
    Int J Cancer. 2021;148:1529-1535.
    >> Share

  21. LOFTUS PG, Watson L, Deedigan LM, Camarillo-Retamosa E, et al
    Targeting stromal cell Syndecan-2 reduces breast tumour growth, metastasis and limits immune evasion.
    Int J Cancer. 2021;148:1245-1259.
    >> Share

  22. AZAM S, Eriksson M, Sjolander A, Gabrielson M, et al
    Predictors of mammographic microcalcifications.
    Int J Cancer. 2021;148:1132-1143.
    >> Share

    February 2021
  23. BELTJENS F, Molly D, Bertaut A, Richard C, et al
    ER-/PR+ breast cancer: a distinct entity, which is morphologically and molecularly close to triple-negative breast cancer.
    Int J Cancer. 2021 Feb 26. doi: 10.1002/ijc.33539.
    >> Share

  24. KIM N, Chang JS, Shah C, Shin H, et al
    Hypofractionated volumetric-modulated arc therapy for breast cancer: A propensity-score-weighted comparison of radiation-related toxicity.
    Int J Cancer. 2021 Feb 18. doi: 10.1002/ijc.33525.
    >> Share

  25. BUCCHI L, Mancini S, Crocetti E, Dal Maso L, et al
    Mid-term trends and recent birth-cohort-dependent changes in incidence rates of cutaneous malignant melanoma in Italy.
    Int J Cancer. 2021;148:835-844.
    >> Share

  26. TRAN QH, Than VT, Luu PL, Clarke D, et al
    A Novel Signature Predicts Recurrence Risk and Therapeutic Response in Breast Cancer Patients.
    Int J Cancer. 2021 Feb 14. doi: 10.1002/ijc.33512.
    >> Share

  27. ARTHUR RS, Dannenberg AJ, Rohan TE
    The association of prediagnostic circulating levels of cardiometabolic markers, testosterone and SHBG with risk of breast cancer among normal weight postmenopausal women in the UK Biobank.
    Int J Cancer. 2021 Feb 10. doi: 10.1002/ijc.33508.
    >> Share

  28. ELGHAZALY H, Aref AT, Anderson BO, Arun B, et al
    The first BGICC consensus and recommendations for breast cancer awareness, early detection and risk reduction in low- and middle-income countries and the MENA Region.
    Int J Cancer. 2021 Feb 9. doi: 10.1002/ijc.33506.
    >> Share

  29. WATT GP, John EM, Bandera EV, Malone KE, et al
    Race, Ethnicity and Risk of Second Primary Contralateral Breast Cancer in the United States.
    Int J Cancer. 2021 Feb 5. doi: 10.1002/ijc.33501.
    >> Share

  30. HEIDRICH I, Ackar L, Mossahebi Mohammadi P, Pantel K, et al
    Liquid biopsies: Potential and challenges.
    Int J Cancer. 2021;148:528-545.
    >> Share

    January 2021
  31. BETHEA TN, Ochs-Balcom HM, Bandera EV, Beeghly-Fadiel A, et al
    First- and second-degree family history of ovarian and breast cancer in relation to risk of invasive ovarian cancer in African American and White women.
    Int J Cancer. 2021 Jan 31. doi: 10.1002/ijc.33493.
    >> Share

  32. TENG NM, Price CA, McKee AM, Hall LJ, et al
    Exploring the impact of gut microbiota and diet on Breast Cancer risk and progression.
    Int J Cancer. 2021 Jan 31. doi: 10.1002/ijc.33496.
    >> Share

  33. OLASEHINDE O, Alatise O, Omisore A, Wuraola F, et al
    Contemporary management of breast cancer in Nigeria: insights from an institutional database.
    Int J Cancer. 2021 Jan 27. doi: 10.1002/ijc.33484.
    >> Share

  34. SACCHETTO L, Rosso S, Comber H, Bouchardy C, et al
    Skin Melanoma Deaths Within 1 Or 3 Years From Diagnosis In Europe.
    Int J Cancer. 2021 Jan 26. doi: 10.1002/ijc.33479.
    >> Share

  35. IWASE M, Matsuo K, Koyanagi YN, Ito H, et al
    Alcohol consumption and breast cancer risk in Japan: a pooled analysis of eight population-based cohort studies.
    Int J Cancer. 2021 Jan 26. doi: 10.1002/ijc.33478.
    >> Share

  36. BYRD DA, Vogtmann E, Wu Z, Han Y, et al
    Associations of fecal microbial profiles with breast cancer and non-malignant breast disease in the Ghana Breast Health Study.
    Int J Cancer. 2021 Jan 18. doi: 10.1002/ijc.33473.
    >> Share

  37. MONESTIER S, Dalle S, Mortier L, Dutriaux C, et al
    Effectiveness and Safety of Nivolumab in Patients with Advanced Melanoma: A Multicenter, Observational Study.
    Int J Cancer. 2021 Jan 11. doi: 10.1002/ijc.33467.
    >> Share

  38. PREOBRAZHENSKAYA EV, Shleykina AU, Gorustovich OA, Martianov AS, et al
    Frequency and molecular characteristics of PALB2-associated cancers in Russian patients.
    Int J Cancer. 2021;148:203-210.
    >> Share

  39. LAMEIJER JRC, Nederend J, Voogd AC, Tjan-Heijnen VCG, et al
    Frequency and diagnostic outcome of bilateral recall at screening mammography.
    Int J Cancer. 2021;148:48-56.
    >> Share

    December 2020
  40. LONJOU C, Eon-Marchais S, Truong T, Dondon MG, et al
    Gene and pathway level analyses of iCOGS variants highlight novel signalling pathways underlying familial breast cancer susceptibility.
    Int J Cancer. 2020 Dec 24. doi: 10.1002/ijc.33457.
    >> Share

  41. MITRA D, Vega-Rubin-de-Celis S, Royla N, Bernhardt S, et al
    Abrogating GPT2 in triple negative breast cancer inhibits tumor growth and promotes autophagy.
    Int J Cancer. 2020 Dec 24. doi: 10.1002/ijc.33456.
    >> Share

  42. KIM S, Park B
    Association between changes in mammographic density category and the risk of breast cancer: A nationwide cohort study in East-Asian women.
    Int J Cancer. 2020 Dec 23. doi: 10.1002/ijc.33455.
    >> Share

    November 2020
  43. VAN DER MEER DJ, Kramer I, van Maaren MC, van Diest PJ, et al
    Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989-2017.
    Int J Cancer. 2020 Nov 30. doi: 10.1002/ijc.33417.
    >> Share

  44. WHITE AJ, Gregoire AM, Taylor KW, Eberle C, et al
    Adolescent use of hair dyes, straighteners and perms in relation to breast cancer risk.
    Int J Cancer. 2020 Nov 30. doi: 10.1002/ijc.33413.
    >> Share

  45. BRILL R, Uller W, Huf V, Muller-Wille R, et al
    Additive value of Transarterial Embolization to systemic Sirolimus treatment in Kaposiform Hemangioendothelioma.
    Int J Cancer. 2020 Nov 24. doi: 10.1002/ijc.33406.
    >> Share

  46. DELLAC S, Ben-Dov H, Raanan A, Saleem H, et al
    Constitutive low expression of antiviral effectors sensitizes melanoma cells to a novel oncolytic virus.
    Int J Cancer. 2020 Nov 16. doi: 10.1002/ijc.33401.
    >> Share

  47. TOGAWA K, Anderson BO, Foerster M, Galukande M, et al
    Geospatial barriers to health care access for breast cancer diagnosis in sub-Saharan African settings: the African Breast Cancer - Disparities in Outcomes (ABC-DO) Cohort Study.
    Int J Cancer. 2020 Nov 16. doi: 10.1002/ijc.33400.
    >> Share

  48. AYENI OA, Norris SA, Joffe M, Cubasch H, et al
    Pre-existing morbidity profile of women newly diagnosed with breast cancer in sub-Saharan Africa: African Breast Cancer-Disparities in Outcomes (ABC-DO) study.
    Int J Cancer. 2020 Nov 12. doi: 10.1002/ijc.33387.
    >> Share

  49. HEO MJ, Kang SH, Kim YS, Lee JM, et al
    UBC12-mediated SREBP-1 neddylation worsens metastatic tumor prognosis.
    Int J Cancer. 2020;147:2550-2563.
    >> Share

    October 2020
  50. DAI WF, Beca J, Croxford R, Isaranuwatchai W, et al
    Real-world, population-based cohort study of toxicity and resource utilization of second-line ipilimumab for metastatic melanoma in Ontario, Canada.
    Int J Cancer. 2020 Oct 26. doi: 10.1002/ijc.33357.
    >> Share

  51. SATAGOPAN JM, Stroup A, Kinney AY, Dharamdasani T, et al
    Breast cancer among Asian Indian and Pakistani Americans: A surveillance, epidemiology and end results-based study.
    Int J Cancer. 2020 Oct 25. doi: 10.1002/ijc.33331.
    >> Share

  52. ZHANG Y, Wang P, Li X, Ning S, et al
    GABC: A Comprehensive Resource and Genome Atlas for Breast Cancer.
    Int J Cancer. 2020 Oct 16. doi: 10.1002/ijc.33347.
    >> Share

  53. ZUPUNSKI L, Yaumenenka A, Ryzhov A, Veyalkin I, et al
    Breast cancer incidence in the regions of Belarus and Ukraine most contaminated by the Chernobyl accident: 1978-2016.
    Int J Cancer. 2020 Oct 16. doi: 10.1002/ijc.33346.
    >> Share

  54. YUAN S, Kar S, Vithayathil M, Carter P, et al
    Causal associations of thyroid function and dysfunction with overall, breast and thyroid cancer: A two-sample Mendelian randomization study.
    Int J Cancer. 2020;147:1895-1903.
    >> Share

    September 2020
  55. KINLEN LJ, Gilham C, Ray R, Thomas DB, et al
    Cohabitation, infection and breast cancer risk.
    Int J Cancer. 2020 Sep 27. doi: 10.1002/ijc.33319.
    >> Share

  56. WEITZER J, Castano-Vinyals G, Aragones N, Gomez-Acebo I, et al
    Effect of time of day of recreational and household physical activity on prostate and breast cancer risk (MCC-Spain Study).
    Int J Cancer. 2020 Sep 25. doi: 10.1002/ijc.33310.
    >> Share

  57. ONG JS, Derks EM, Eriksson M, An J, et al
    Evaluating the role of alcohol consumption in breast and ovarian cancer susceptibility using population-based cohort studies and two-sample Mendelian randomization analyses.
    Int J Cancer. 2020 Sep 25. doi: 10.1002/ijc.33308.
    >> Share

  58. TAN PS, Alsheh Ali M, Eriksson M, Hall P, et al
    Mammography features for early markers of aggressive breast cancer subtypes and tumor characteristics - a population-based cohort study.
    Int J Cancer. 2020 Sep 25. doi: 10.1002/ijc.33309.
    >> Share

  59. STALIN J, Traboulsi W, Vivancos-Stalin L, Nollet M, et al
    Therapeutic targeting of soluble CD146/MCAM with the M2J-1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146-positive invasive tumors.
    Int J Cancer. 2020;147:1666-1679.
    >> Share

  60. APOSTOLOU P, Fostira F, Kouroussis C, Kalfakakou D, et al
    BRCA1 and BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects.
    Int J Cancer. 2020;147:1334-1342.
    >> Share

    August 2020
  61. UGALDE-MORALES E, Grassmann F, Humphreys K, Li J, et al
    Association between breast cancer risk and disease aggressiveness: characterizing underlying gene expression patterns.
    Int J Cancer. 2020 Aug 28. doi: 10.1002/ijc.33270.
    >> Share

  62. BOARD R, Smittenaar R, Lawton S, Liu H, et al
    Metastatic melanoma patient outcomes since introduction of immune checkpoint inhibitors in England between 2014 and 2018.
    Int J Cancer. 2020 Aug 24. doi: 10.1002/ijc.33266.
    >> Share

  63. WANG F, Meszoely I, Pal T, Mayer IA, et al
    Radiotherapy After Breast Conserving Surgery for Elderly Patients with Early-Stage Breast Cancer: A National Registry Based Study.
    Int J Cancer. 2020 Aug 24. doi: 10.1002/ijc.33265.
    >> Share

  64. SATO M, Onuma K, Domon M, Hasegawa S, et al
    Loss of the cystine/glutamate antiporter in melanoma abrogates tumor metastasis and dramatically increases survival rates of mice.
    Int J Cancer. 2020 Aug 20. doi: 10.1002/ijc.33262.
    >> Share

  65. ZHAO Y, Amorrortu RP, Fenske NA, Cherpelis B, et al
    Cutaneous viral infections associated with ultraviolet radiation exposure.
    Int J Cancer. 2020 Aug 20. doi: 10.1002/ijc.33263.
    >> Share

  66. MENGONI M, Braun AD, Gaffal E, Tuting T, et al
    The aryl hydrocarbon receptor promotes inflammation-induced dedifferentiation and systemic metastatic spread of melanoma cells.
    Int J Cancer. 2020 Aug 13. doi: 10.1002/ijc.33252.
    >> Share

  67. PAPADIMITRIOU N, Dimou N, Gill D, Tzoulaki I, et al
    Genetically predicted circulating concentrations of micro-nutrients and risk of breast cancer: A Mendelian randomization study.
    Int J Cancer. 2020 Aug 5. doi: 10.1002/ijc.33246.
    >> Share

  68. GAO C, Wang F, Suki D, Strom E, et al
    Effects of systemic therapy and local therapy on outcomes of 873 breast cancer patients with metastatic breast cancer to brain: MD Anderson Cancer Center experience.
    Int J Cancer. 2020 Aug 4. doi: 10.1002/ijc.33243.
    >> Share

  69. WALPOLE E, Dunn N, Youl P, Harden H, et al
    Nonbreast cancer incidence, treatment received and outcomes: Are there differences in breast screening attendees versus nonattendees?
    Int J Cancer. 2020;147:856-865.
    >> Share

  70. CARIOLI G, Bertuccio P, Malvezzi M, Rodriguez T, et al
    Cancer mortality predictions for 2019 in Latin America.
    Int J Cancer. 2020;147:619-632.
    >> Share

    July 2020
  71. ZHANG J, Yao L, Liu Y, Ouyang T, et al
    Impact of the addition of carboplatin to anthracycline-taxane-based neoadjuvant chemotherapy on survival in BRCA1/2-mutated triple-negative breast cancer.
    Int J Cancer. 2020 Jul 28. doi: 10.1002/ijc.33234.
    >> Share

  72. BARENHOLZ-COHEN T, Merkher Y, Haj J, Shechter D, et al
    Lung mechanics modifications facilitating metastasis are mediated in part by breast cancer derived extracellular vesicles.
    Int J Cancer. 2020 Jul 23. doi: 10.1002/ijc.33229.
    >> Share

  73. YI ZB, Yu P, Zhang S, Wang WN, et al
    Profile and outcome of receptor conversion in breast cancer metastases: a nation-wide multicenter epidemiological study.
    Int J Cancer. 2020 Jul 23. doi: 10.1002/ijc.33227.
    >> Share

  74. WANG X, Yu B, Cao B, Zhou J, et al
    A chemical conjugation of JQ-1 and a TLR7 agonist induces tumoricidal effects in a murine model of melanoma via enhanced immunomodulation.
    Int J Cancer. 2020 Jul 19. doi: 10.1002/ijc.33222.
    >> Share

  75. JABAGI MJ, Vey N, Goncalves A, Le Tri T, et al
    Risk of secondary hematologic malignancies associated with breast cancer chemotherapy and G-CSF support: a nationwide population-based cohort.
    Int J Cancer. 2020 Jul 19. doi: 10.1002/ijc.33216.
    >> Share

  76. ZIELONKE N, Kregting LM, Heijnsdijk EAM, Veerus P, et al
    The potential of breast cancer screening in Europe.
    Int J Cancer. 2020 Jul 19. doi: 10.1002/ijc.33204.
    >> Share

  77. FOERSTER M, McKenzie F, Zietsman A, Galukande M, et al
    Dissecting the journey to breast cancer diagnosis in sub-Saharan Africa: Findings from the multi-country ABC-DO cohort study.
    Int J Cancer. 2020 Jul 14. doi: 10.1002/ijc.33209.
    >> Share

  78. AKCAY IM, Celik E, Agaoglu NB, Alkurt G, et al
    Germline pathogenic variant spectrum in 25 cancer susceptibility genes in Turkish breast and colorectal cancer patients and elderly controls.
    Int J Cancer. 2020 Jul 13. doi: 10.1002/ijc.33199.
    >> Share

  79. JUNG AY, Husing A, Behrens S, Krzykalla J, et al
    Postdiagnosis weight change is associated with poorer survival in breast cancer survivors: A prospective population-based patient cohort study.
    Int J Cancer. 2020 Jul 4. doi: 10.1002/ijc.33181.
    >> Share

  80. XIE Y, Valdimarsdottir UA, Wang C, Zhong X, et al
    Public health insurance and cancer-specific mortality risk among patients with breast cancer: a prospective cohort study in China.
    Int J Cancer. 2020 Jul 4. doi: 10.1002/ijc.33183.
    >> Share

  81. PONTI A, Basu P, Ritchie D, Anttila A, et al
    Key issues that need to be considered while revising the current annex of the European Council Recommendation (2003) on cancer screening.
    Int J Cancer. 2020;147:9-13.
    >> Share

    June 2020
  82. CHEN Y, Guan Y, Wang J, Ma F, et al
    Platinum-based chemotherapy in advanced triple-negative breast cancer: a multicenter real-world study in China.
    Int J Cancer. 2020 Jun 25. doi: 10.1002/ijc.33175.
    >> Share

  83. WANG T, Bradshaw PT, Moorman PG, Nyante SJ, et al
    Menopausal hormone therapy use and long-term all-cause and cause-specific mortality in the Long Island Breast Cancer Study Project.
    Int J Cancer. 2020 Jun 25. doi: 10.1002/ijc.33174.
    >> Share

  84. VAN ZEIJL MCT, Ismail RK, de Wreede LC, van den Eertwegh AJM, et al
    Real-world outcomes of advanced melanoma patients not represented in phase III trials.
    Int J Cancer. 2020 Jun 19. doi: 10.1002/ijc.33162.
    >> Share

  85. TOSS A, Lambertini M, Punie K, Grandi G, et al
    BREAST CANCER SCREENING OF MUTATION CARRIERS IN THE ERA OF COVID-19 PANDEMIC.
    Int J Cancer. 2020 Jun 17. doi: 10.1002/ijc.33160.
    >> Share

  86. LAN B, Abudureheiyimu N, Zhang J, Wang C, et al
    Clinical features and prognostic factors for extracranial oligometastatic breast cancer in China.
    Int J Cancer. 2020 Jun 14. doi: 10.1002/ijc.33152.
    >> Share

  87. VON DER LIPPE GYTHFELDT H, Lien T, Tekpli X, Silwal-Pandit L, et al
    Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER positive breast cancer.
    Int J Cancer. 2020 Jun 3. doi: 10.1002/ijc.33108.
    >> Share

  88. SANKATSING VDV, van Ravesteyn NT, Heijnsdijk EAM, Broeders MJM, et al
    Risk stratification in breast cancer screening: cost-effectiveness and harm-benefit ratios for low-risk and high-risk women.
    Int J Cancer. 2020 Jun 2. doi: 10.1002/ijc.33126.
    >> Share

  89. XIAO Q, James P, Breheny P, Jia P, et al
    Outdoor light at night and postmenopausal breast cancer risk in the NIH-AARP diet and health study.
    Int J Cancer. 2020 Jun 2. doi: 10.1002/ijc.33016.
    >> Share

    May 2020
  90. RIEDEL F, Hoffmann AS, Moderow M, Heublein S, et al
    Time Trends of Neoadjuvant Chemotherapy for Early Breast Cancer.
    Int J Cancer. 2020 May 28. doi: 10.1002/ijc.33122.
    >> Share

  91. ZONNEVILLE J, Colligan S, Grant S, Miller A, et al
    Blockade of p38 kinase impedes the mobilization of protumorigenic myeloid populations to impact breast cancer metastasis.
    Int J Cancer. 2020 May 25. doi: 10.1002/ijc.33050.
    >> Share

  92. STANG A, Wellmann I, Kajuter H, Trocchi P, et al
    Differences in site-specific incidence and relative survival of cutaneous and mucocutaneous genital squamous cell carcinoma in Germany, 2007-2015.
    Int J Cancer. 2020 May 23. doi: 10.1002/ijc.33109.
    >> Share

  93. HE Q, Li X, He L, Li Y, et al
    Pericyte dysfunction due to Shb gene deficiency increases B16F10 melanoma lung metastasis.
    Int J Cancer. 2020 May 22. doi: 10.1002/ijc.33110.
    >> Share

  94. SRINIVAS N, Neittaanmaki N, Heidenreich B, Rachakonda S, et al
    TERT promoter mutations in actinic keratosis before and after treatment.
    Int J Cancer. 2020;146:2932-2934.
    >> Share

  95. HILBERS FS, van 't Hof PJ, Meijers CM, Mei H, et al
    Clustering of known low and moderate risk alleles rather than a novel recessive high-risk gene in non-BRCA1/2 sib trios affected with breast cancer.
    Int J Cancer. 2020 May 7. doi: 10.1002/ijc.33039.
    >> Share

  96. SANDSVEDEN M, Nilsssson E, Borgquist S, Rosendahl AH, et al
    Pre-diagnostic serum selenium levels in relation to breast cancer survival and tumor characteristics.
    Int J Cancer. 2020 May 6. doi: 10.1002/ijc.33031.
    >> Share

  97. CARRERAS G, Lachi A, Boffi R, Clancy L, et al
    Burden of disease from breast cancer attributable to smoking and second-hand smoke exposure in Europe.
    Int J Cancer. 2020 May 1. doi: 10.1002/ijc.33021.
    >> Share

    April 2020
  98. JOKO-FRU WY, Jedy-Agba E, Korir A, Ogunbiyi O, et al
    The evolving epidemic of breast cancer in sub-Saharan Africa. Results from the African Cancer Registry Network.
    Int J Cancer. 2020 Apr 19. doi: 10.1002/ijc.33014.
    >> Share

  99. ZAHL PH, Kalager M, Suhrke P, Nord E, et al
    Quality-of-life effects of screening mammography in Norway.
    Int J Cancer. 2020;146:2104-2112.
    >> Share

  100. ROBINSON SN, Zens MS, Rees JR, Barton DT, et al
    Risk of Melanoma Following Keratinocyte Malignancies.
    Int J Cancer. 2020 Apr 14. doi: 10.1002/ijc.33011.
    >> Share

  101. ZHENG S, Zou Y, Xie X, Liang JY, et al
    Development and Validation of a Stromal Immune Phenotype Classifier for Predicting Immune Activity and Prognosis in Triple-Negative Breast Cancer.
    Int J Cancer. 2020 Apr 14. doi: 10.1002/ijc.33009.
    >> Share

  102. TSENG HY, Dreyer J, Al Emran A, Gunatilake D, et al
    Co-targeting BET proteins and MCL1 induces synergistic cell death in melanoma.
    Int J Cancer. 2020 Apr 5. doi: 10.1002/ijc.33000.
    >> Share

    March 2020
  103. KUMAR S, Xie H, Shi H, Gao J, et al
    Merkel cell polyomavirus oncoproteins induce microRNAs that suppress multiple autophagy genes.
    Int J Cancer. 2020;146:1652-1666.
    >> Share

  104. ARMAROLI P, Riggi E, Basu P, Anttila A, et al
    Performance Indicators in Breast Cancer Screening in the European Union: A Comparison Across Countries of Screen Positivity and Detection Rates.
    Int J Cancer. 2020 Mar 11. doi: 10.1002/ijc.32968.
    >> Share

  105. ROBINSON T, Martin RM, Yarmolinsky J
    Mendelian Randomization Analysis of Circulating Adipokines and C-reactive Protein on Breast Cancer Risk.
    Int J Cancer. 2020 Mar 5. doi: 10.1002/ijc.32947.
    >> Share

  106. YIN S, Wang N, Riabov V, Mossel DM, et al
    SI-CLP inhibits the growth of mouse mammary adenocarcinoma by preventing recruitment of tumor-associated macrophages.
    Int J Cancer. 2020;146:1396-1408.
    >> Share

  107. QI L, Zhang Q, Miao Y, Kang W, et al
    Interleukin-33 activates and recruits natural killer cells to inhibit pulmonary metastatic cancer development.
    Int J Cancer. 2020;146:1421-1434.
    >> Share

    February 2020
  108. FARES J, Kanojia D, Rashidi A, Ulasov I, et al
    Landscape of Combination Therapy Trials in Breast Cancer Brain Metastasis.
    Int J Cancer. 2020 Feb 22. doi: 10.1002/ijc.32937.
    >> Share

  109. FUNCK-BRENTANO E, Baghad B, Fort M, Aouidad I, et al
    Efficacy of late concurrent hypofractionated radiotherapy in advanced melanoma patients failing anti-PD-1 monotherapy.
    Int J Cancer. 2020 Feb 21. doi: 10.1002/ijc.32934.
    >> Share

  110. FIGUEROA JD, Davis Lynn BC, Edusei L, Titiloye N, et al
    Reproductive Factors and Risk of Breast Cancer by Tumor Subtypes among Ghanaian Women: A Population-based Case-control Study.
    Int J Cancer. 2020 Feb 18. doi: 10.1002/ijc.32929.
    >> Share

  111. BAADE PD, Whiteman DC, Janda M, Cust AE, et al
    Long-Term Deaths From Melanoma According To Tumour Thickness At Diagnosis.
    Int J Cancer. 2020 Feb 17. doi: 10.1002/ijc.32930.
    >> Share

  112. ISLAMI F, Sauer AG, Miller KD, Fedewa SA, et al
    Cutaneous melanomas attributable to ultraviolet radiation exposure by state.
    Int J Cancer. 2020 Feb 17. doi: 10.1002/ijc.32921.
    >> Share

  113. PERSSON H, Sokilde R, Hakkinen J, Vallon-Christersson J, et al
    Analysis of fusion transcripts indicates widespread deregulation of snoRNAs and their host genes in breast cancer.
    Int J Cancer. 2020 Feb 17. doi: 10.1002/ijc.32927.
    >> Share

  114. LIU ZH, Chen ML, Zhang Q, Zhang Y, et al
    ZIC2 is downregulated and represses tumor growth via the regulation of STAT3 in breast cancer.
    Int J Cancer. 2020 Feb 16. doi: 10.1002/ijc.32922.
    >> Share

  115. JOHN EM, Phipps AI, Hines LM, Koo J, et al
    Menstrual and reproductive characteristics and breast cancer risk by hormone receptor status and race/ethnicity: The Breast Cancer Etiology in Minorities (BEM) Study.
    Int J Cancer. 2020 Feb 16. doi: 10.1002/ijc.32923.
    >> Share

  116. ZAHL PH, Kalager M
    Reply to: Loss of QALY in mammography screening reported by Zahl et al.
    Int J Cancer. 2020;146:1177.
    >> Share

  117. NJOR SH, Lynge E
    Loss of QALY in mammography screening reported by Zahl et al.
    Int J Cancer. 2020;146:1176.
    >> Share

  118. SU L, Xu Y, Ouyang T, Li J, et al
    Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers in a large cohort of unselected Chinese breast cancer patients.
    Int J Cancer. 2020 Feb 9. doi: 10.1002/ijc.32918.
    >> Share

  119. ZENG, Liang YK, Xiao YS, Wei XL, et al
    Inhibition of Notch1 reverses EMT and chemoresistance to cisplatin via direct down-regulation of MCAM in triple-negative breast cancer cells.
    Int J Cancer. 2020 Feb 5. doi: 10.1002/ijc.32911.
    >> Share

  120. HENSON KE, McGale P, Darby SC, Parkin DM, et al
    Cardiac Mortality after Radiotherapy, Chemotherapy and Endocrine Therapy for Breast Cancer: Cohort Study of 2 Million Women from 57 Cancer Registries in 22 Countries.
    Int J Cancer. 2020 Feb 5. doi: 10.1002/ijc.32908.
    >> Share

  121. CHANG VC, Cotterchio M, Bondy SJ, Kotsopoulos J, et al
    Iron intake, oxidative stress-related genes, and breast cancer risk.
    Int J Cancer. 2020 Feb 5. doi: 10.1002/ijc.32906.
    >> Share

  122. XIAO Q, Zhou Y, Winter S, Buttner F, et al
    Germline variant burden in multidrug resistance transporters is a therapy-specific predictor of survival in breast cancer patients.
    Int J Cancer. 2020 Feb 3. doi: 10.1002/ijc.32898.
    >> Share

  123. SCHOEMAKER MJ, Nichols HB, Wright LB, Brook MN, et al
    Adult weight change and premenopausal breast cancer risk: A prospective pooled analysis of data from 628,463 women.
    Int J Cancer. 2020 Feb 3. doi: 10.1002/ijc.32892.
    >> Share

    January 2020
  124. MENG H, Yao L, Yuan H, Xu Y, et al
    BRCA1 c.5470_5477del, a founder mutation in Chinese Han breast cancer patients.
    Int J Cancer. 2020 Jan 20. doi: 10.1002/ijc.32877.
    >> Share

  125. JOHNSTONE CN, Pattison AD, Harrison PF, Powell DR, et al
    FGF13 promotes metastasis of triple-negative breast cancer.
    Int J Cancer. 2020 Jan 19. doi: 10.1002/ijc.32874.
    >> Share

  126. CHOU WC, Hsiung CN, Chen WT, Tseng LM, et al
    A Functional Variant Near XCL1 Gene Improves Breast Cancer Survival via Promoting Cancer Immunity.
    Int J Cancer. 2020 Jan 6. doi: 10.1002/ijc.32855.
    >> Share

  127. ALIPOUR S
    Comments on: Hair dye and chemical straightener use and breast cancer risk in a large US population of black and white women.
    Int J Cancer. 2020 Jan 6. doi: 10.1002/ijc.32852.
    >> Share

  128. SONNENBLICK A, Salmon-Divon M, Salgado R, Dvash E, et al
    Reactive stroma and trastuzumab resistance in HER2-positive early breast cancer.
    Int J Cancer. 2020 Jan 6. doi: 10.1002/ijc.32859.
    >> Share

  129. VANGANGELT KMH, Green AR, Heemskerk IMF, Cohen D, et al
    The prognostic value of the tumor-stroma ratio is most discriminative in patients with grade III or triple negative breast cancer.
    Int J Cancer. 2020 Jan 4. doi: 10.1002/ijc.32857.
    >> Share

  130. NOME ME, Euceda LR, Jabeen S, Debik J, et al
    Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers.
    Int J Cancer. 2020;146:223-235.
    >> Share

    December 2019
  131. RAINEY L, Eriksson M, Trinh T, Czene K, et al
    The impact of alcohol consumption and physical activity on breast cancer: the role of breast cancer risk.
    Int J Cancer. 2019 Dec 21. doi: 10.1002/ijc.32846.
    >> Share

  132. GUO X, Long J, Chen Z, Shu XO, et al
    Discovery of rare coding variants in OGDHL and BRCA2 in relation to breast cancer risk in Chinese women.
    Int J Cancer. 2019 Dec 13. doi: 10.1002/ijc.32825.
    >> Share

  133. ZHANG D, Nichols HB, Troester M, Cai J, et al
    Tea consumption and breast cancer risk in a cohort of women with family history of breast cancer.
    Int J Cancer. 2019 Dec 13. doi: 10.1002/ijc.32824.
    >> Share

  134. EBERLE CE, Sandler DP, Taylor KW, White AJ, et al
    Hair dye and chemical straightener use and breast cancer risk in a large US population of black and white women.
    Int J Cancer. 2019 Dec 3. doi: 10.1002/ijc.32738.
    >> Share

  135. SALA L, Franco-Valls H, Stanisavljevic J, Curto J, et al
    Abrogation of myofibroblast activities in metastasis and fibrosis by methyltransferase inhibition.
    Int J Cancer. 2019;145:3064-3077.
    >> Share

    November 2019
  136. SUNG H, Devi BCR, Tang TS, Rosenberg PS, et al
    Divergent breast cancer incidence trends by hormone receptor status in the state of Sarawak, Malaysia.
    Int J Cancer. 2019 Nov 28. doi: 10.1002/ijc.32812.
    >> Share

  137. NOH H, Charvat H, Freisling H, Olafsdottir GH, et al
    Cumulative exposure to premenopausal obesity and risk of postmenopausal cancer: A population-based study in Icelandic women.
    Int J Cancer. 2019 Nov 21. doi: 10.1002/ijc.32805.
    >> Share

  138. LIEB WS, Lungu C, Tamas R, Berreth H, et al
    The GEF-H1/PKD3 signaling pathway promotes the maintenance of triple negative breast cancer stem cells.
    Int J Cancer. 2019 Nov 19. doi: 10.1002/ijc.32798.
    >> Share

  139. DE VINCENZO A, Belli S, Franco P, Telesca M, et al
    Paracrine recruitment and activation of fibroblasts by c-Myc expressing breast epithelial cells through the IGFs/IGF-1R axis.
    Int J Cancer. 2019;145:2827-2839.
    >> Share

  140. BASSAN D, Gozlan YM, Sharbi-Yunger A, Tzehoval E, et al
    Optimizing T-cell receptor avidity with somatic hypermutation.
    Int J Cancer. 2019;145:2816-2826.
    >> Share

  141. LAMBERTINI M, Poggio F, Bruzzone M, Conte B, et al
    Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: exploratory analysis of the GIM2 trial.
    Int J Cancer. 2019 Nov 13. doi: 10.1002/ijc.32789.
    >> Share

  142. HEEG E, Marang-van de Mheen PJ, Van Maaren MC, Schreuder K, et al
    Association between Initiation of Adjuvant Chemotherapy Beyond 30 Days Following Surgery and Overall Survival Among Patients With Triple-Negative Breast Cancer.
    Int J Cancer. 2019 Nov 12. doi: 10.1002/ijc.32788.
    >> Share

  143. BELLMANN L, Cappellano G, Schachtl-Riess JF, Prokopi A, et al
    A TLR7 agonist strengthens T and NK cell function during BRAF-targeted therapy in a preclinical melanoma model.
    Int J Cancer. 2019 Nov 8. doi: 10.1002/ijc.32777.
    >> Share

  144. STOTH M, Freire Valls A, Chen M, Hidding S, et al
    Splenectomy reduces lung metastases and tumoral and metastatic niche inflammation.
    Int J Cancer. 2019;145:2509-2520.
    >> Share

  145. KATALINIC A, Eisemann N, Kraywinkel K, Noftz MR, et al
    Breast cancer incidence and mortality before and after implementation of the German mammography screening program.
    Int J Cancer. 2019 Nov 1. doi: 10.1002/ijc.32767.
    >> Share

    October 2019
  146. WU Y, Wang Y, Wang L, Yin P, et al
    Burden of Melanoma in China, 1990-2017: Findings from the 2017 Global Burden of Disease Study.
    Int J Cancer. 2019 Oct 31. doi: 10.1002/ijc.32764.
    >> Share

  147. ZHOU Y, Huang Z, Su J, Li J, et al
    Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment.
    Int J Cancer. 2019 Oct 25. doi: 10.1002/ijc.32756.
    >> Share

  148. BLAZQUEZ R, Rietkotter E, Wenske B, Wlochowitz D, et al
    LEF1 supports metastatic brain colonization by regulating glutathione metabolism and increasing ROS resistance in breast cancer.
    Int J Cancer. 2019 Oct 18. doi: 10.1002/ijc.32742.
    >> Share

  149. NGUYEN TL, Li S, Dite GS, Aung YK, et al
    Interval Breast Cancer Risk Associations with Breast Density, Family History, and Breast Tissue Ageing.
    Int J Cancer. 2019 Oct 14. doi: 10.1002/ijc.32731.
    >> Share

  150. AYENI OA, Norris SA, Joffe M, Cubasch H, et al
    The multimorbidity profile of South African women newly diagnosed with breast cancer.
    Int J Cancer. 2019 Oct 10. doi: 10.1002/ijc.32727.
    >> Share

  151. VAN HEMELRIJCK WMJ, De Schutter H, de Valk HAG, Silversmit G, et al
    Breast cancer by migrant background in Belgium: lower risk, but worse survival in women of non-European origin.
    Int J Cancer. 2019 Oct 9. doi: 10.1002/ijc.32726.
    >> Share

  152. LI X, Wu W, Giovannucci E, Stampfer MJ, et al
    Cutaneous nevi and internal cancer risk: results from two large prospective cohorts of US women.
    Int J Cancer. 2019 Oct 8. doi: 10.1002/ijc.32703.
    >> Share

  153. LUO J, Chen X, Manson JE, Shadyab AH, et al
    Birth weight, weight over the adult life course, and risk of breast cancer.
    Int J Cancer. 2019 Oct 4. doi: 10.1002/ijc.32710.
    >> Share

  154. VAN OPIJNEN MP, Dirven L, Coremans IEM, Taphoorn MJB, et al
    The impact of current treatment modalities on the outcomes of patients with melanoma brain metastases: a systematic review.
    Int J Cancer. 2019 Oct 3. doi: 10.1002/ijc.32696.
    >> Share

  155. CATTERALL R, Lelarge V, McCaffrey L
    Genetic Alterations of Epithelial Polarity Genes are Associated with Loss of Polarity in Invasive Breast Cancer.
    Int J Cancer. 2019 Oct 2. doi: 10.1002/ijc.32691.
    >> Share

  156. JOHANSSON ALV, Ursin G
    Reply to: "Detection by screening introduces biases into survival estimates for luminal A-like breast cancer patients".
    Int J Cancer. 2019 Oct 1. doi: 10.1002/ijc.32699.
    >> Share

  157. BUCCHI L, Ravaioli A, Mancini S, Baldacchini F, et al
    Detection by screening introduces biases into survival estimates for luminal A-like breast cancer patients.
    Int J Cancer. 2019 Oct 1. doi: 10.1002/ijc.32697.
    >> Share

    September 2019
  158. CERVENKA I, Al Rahmoun M, Mahamat-Saleh Y, Fournier A, et al
    Exogenous Hormone Use and Cutaneous Melanoma Risk in Women: The European Prospective Investigation Into Cancer and Nutrition.
    Int J Cancer. 2019 Sep 10. doi: 10.1002/ijc.32674.
    >> Share

  159. KRUGER DT, Alexi X, Opdam M, Schuurman K, et al
    IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancer.
    Int J Cancer. 2019 Sep 6. doi: 10.1002/ijc.32668.
    >> Share

  160. FONTI C, Saumet A, Abi-Khalil A, Orsetti B, et al
    Distinct oncogenes drive different genome and epigenome alterations in human mammary epithelial cells.
    Int J Cancer. 2019;145:1299-1311.
    >> Share

  161. KONG Y, Wang Z, Huang M, Zhou Z, et al
    CUL7 promotes cancer cell survival through promoting Caspase-8 ubiquitination.
    Int J Cancer. 2019;145:1371-1381.
    >> Share

  162. GRUNEWALD S, Politz O, Bender S, Heroult M, et al
    Rogaratinib: A potent and selective pan-FGFR inhibitor with broad antitumor activity in FGFR-overexpressing preclinical cancer models.
    Int J Cancer. 2019;145:1346-1357.
    >> Share

    August 2019
  163. PRAJZENDANC K, Domagala P, Hybiak J, Rys J, et al
    BRCA1 promoter methylation in peripheral blood is associated with the risk of triple-negative breast cancer.
    Int J Cancer. 2019 Aug 30. doi: 10.1002/ijc.32655.
    >> Share

  164. MANICHAIKUL A, Peres LC, Wang XQ, Barnard ME, et al
    Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.
    Int J Cancer. 2019 Aug 30. doi: 10.1002/ijc.32653.
    >> Share

  165. SILLING S, Soylemez U, Mauch C, Zigrino P, et al
    Human papillomavirus type 197 is not associated with skin tumors.
    Int J Cancer. 2019 Aug 28. doi: 10.1002/ijc.32646.
    >> Share

  166. ARROYO MUHR LS, Dillner J
    Reply to: Human papillomavirus type 197 is not associated with skin tumors.
    Int J Cancer. 2019 Aug 28. doi: 10.1002/ijc.32645.
    >> Share

  167. BRUSCO I, Li Puma S, Chiepe KB, da Silva Brum E, et al
    Dacarbazine alone or associated with melanoma-bearing cancer pain model induces painful hypersensitivity by TRPA1 activation in mice.
    Int J Cancer. 2019 Aug 28. doi: 10.1002/ijc.32648.
    >> Share

  168. DEMARK-WAHNEFRIED W, Rogers LQ, Gibson JT, Harada S, et al
    Randomized Trial of Weight Loss in Primary Breast Cancer: Impact on Body Composition, Circulating Biomarkers and Tumor Characteristics.
    Int J Cancer. 2019 Aug 23. doi: 10.1002/ijc.32637.
    >> Share

  169. ELLEBAEK E, Bastholt L, Schmidt H, Svane IM, et al
    The real-world outcome of metastatic melanoma: unknown primary versus known cutaneous.
    Int J Cancer. 2019 Aug 19. doi: 10.1002/ijc.32631.
    >> Share

  170. VERVER D, van der Veldt A, van Akkooi A, Verhoef C, et al
    Reply to: The real-world outcome of metastatic melanoma: unknown primary versus known cutaneous.
    Int J Cancer. 2019 Aug 19. doi: 10.1002/ijc.32630.
    >> Share

  171. SCHRAMA D, Sarosi EM, Adam C, Ritter C, et al
    Characterization of six Merkel cell polyomavirus-positive Merkel cell carcinoma cell lines: Integration pattern suggest that large T antigen truncating events occur before or during integration.
    Int J Cancer. 2019;145:1020-1032.
    >> Share

  172. OUDANONH T, Nabi H, Ennour-Idrissi K, Lemieux J, et al
    Progesterone receptor status modifies the association between body mass index and prognosis in women diagnosed with estrogen receptor positive breast cancer.
    Int J Cancer. 2019 Aug 12. doi: 10.1002/ijc.32621.
    >> Share

  173. LO JJ, Park YM, Sinha R, Sandler DP, et al
    Association between meat consumption and risk of breast cancer: Findings from the Sister Study.
    Int J Cancer. 2019 Aug 6. doi: 10.1002/ijc.32547.
    >> Share

  174. FURFARO AL, Ottonello S, Loi G, Cossu I, et al
    HO-1 downregulation favors BRAF(V600) melanoma cell death induced by Vemurafenib/PLX4032 and increases NK recognition.
    Int J Cancer. 2019 Aug 3. doi: 10.1002/ijc.32611.
    >> Share

    July 2019
  175. MARCINIAK W, Derkacz R, Muszynska M, Baszuk P, et al
    Blood Arsenic Levels and the Risk of Familial Breast Cancer in Poland.
    Int J Cancer. 2019 Jul 26. doi: 10.1002/ijc.32595.
    >> Share

  176. DIETERICH LC, Kapaklikaya K, Cetintas T, Proulx ST, et al
    Transcriptional profiling of breast cancer-associated lymphatic vessels reveals VCAM-1 as regulator of lymphatic invasion and permeability.
    Int J Cancer. 2019 Jul 25. doi: 10.1002/ijc.32594.
    >> Share

  177. CHAN YT, Lai AC, Lin RJ, Wang YH, et al
    GPER-induced signaling is essential for the survival of breast cancer stem cells.
    Int J Cancer. 2019 Jul 24. doi: 10.1002/ijc.32588.
    >> Share

  178. PIZZUTI L, Krasniqi E, Barchiesi G, Della Giulia M, et al
    Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.
    Int J Cancer. 2019 Jul 22. doi: 10.1002/ijc.32583.
    >> Share

  179. VAN OURTI T, O'Donnell O, Koc H, Fracheboud J, et al
    Effect of screening mammography on breast-cancer mortality: Quasi-experimental evidence from rollout of the Dutch population-based program with 17-year follow-up of a cohort.
    Int J Cancer. 2019 Jul 22. doi: 10.1002/ijc.32584.
    >> Share

  180. BAI L, Shin S, Burnett RT, Kwong JC, et al
    Exposure to ambient air pollution and the incidence of lung cancer and breast cancer in the Ontario Population Health and Environment Cohort (ONPHEC).
    Int J Cancer. 2019 Jul 15. doi: 10.1002/ijc.32575.
    >> Share

  181. LABO N, Marshall V, Miley W, Davis E, et al
    Mutual detection of Kaposi's sarcoma-associated-Herpesvirus and Epstein Barr virus in blood and saliva of Cameroonians with and without Kaposi's sarcoma.
    Int J Cancer. 2019 Jul 2. doi: 10.1002/ijc.32546.
    >> Share

  182. SHU X, Bao J, Wu L, Long J, et al
    Evaluation of Associations between Genetically Predicted Circulating Protein Biomarkers and Breast Cancer Risk.
    Int J Cancer. 2019 Jul 2. doi: 10.1002/ijc.32542.
    >> Share

    June 2019
  183. BRENTNALL AR, van Veen EM, Harkness EF, Rafiq S, et al
    A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density.
    Int J Cancer. 2019 Jun 28. doi: 10.1002/ijc.32541.
    >> Share

  184. MA F, Guan Y, Yi Z, Chang L, et al
    Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer.
    Int J Cancer. 2019 Jun 26. doi: 10.1002/ijc.32536.
    >> Share

  185. PERSON H, Guillemin F, Conroy T, Velten M, et al
    Factors of the evolution of fatigue dimensions in patients with breast cancer during the 2 years after surgery.
    Int J Cancer. 2019 Jun 22. doi: 10.1002/ijc.32527.
    >> Share

  186. GENG N, Li Y, Zhang W, Wang F, et al
    A PAK5-DNPEP-USP4 axis dictates breast cancer growth and metastasis.
    Int J Cancer. 2019 Jun 20. doi: 10.1002/ijc.32523.
    >> Share

  187. GENER LAHAV T, Adler O, Zait Y, Shani O, et al
    Melanoma-derived extracellular vesicles instigate pro-inflammatory signaling in the metastatic microenvironment.
    Int J Cancer. 2019 Jun 19. doi: 10.1002/ijc.32521.
    >> Share

  188. SINGH D, Malila N, Pitkaniemi J, Anttila A, et al
    Cancer incidence and mortality patterns in women with breast symptoms in the mammography screening programme: A matched cohort analysis.
    Int J Cancer. 2019;144:2928-2935.
    >> Share

  189. KINOSHITA R, Sato H, Yamauchi A, Takahashi Y, et al
    exSSSRs (extracellular S100 soil sensor receptors)-Fc fusion proteins work as prominent decoys to S100A8/A9-induced lung tropic cancer metastasis.
    Int J Cancer. 2019;144:3138-3145.
    >> Share

  190. DASHTI SG, Simpson JA, Karahalios A, Viallon V, et al
    Adiposity and estrogen receptor-positive, postmenopausal breast cancer risk: quantification of the mediating effects of fasting insulin and free estradiol.
    Int J Cancer. 2019 Jun 12. doi: 10.1002/ijc.32504.
    >> Share

  191. CYBULSKI C, Kluzniak W, Huzarski T, Wokolorczyk D, et al
    The Spectrum of Mutations Predisposing to Familial Breast Cancer in Poland.
    Int J Cancer. 2019 Jun 7. doi: 10.1002/ijc.32492.
    >> Share

  192. WANG S, Pitt JJ, Zheng Y, Yoshimatsu TF, et al
    Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria.
    Int J Cancer. 2019 Jun 7. doi: 10.1002/ijc.32498.
    >> Share

  193. AN KY, Morielli AR, Kang DW, Friedenreich CM, et al
    Effects of exercise dose and type during breast cancer chemotherapy on longer-term patient-reported outcomes and health-related fitness: A randomized controlled trial.
    Int J Cancer. 2019 Jun 7. doi: 10.1002/ijc.32493.
    >> Share

  194. GLUZ O, Kolberg-Liedtke C, Prat A, Christgen M, et al
    Efficacy of de-escalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer: Primary translational analysis of the WSG-ADAPT-TN trial.
    Int J Cancer. 2019 Jun 4. doi: 10.1002/ijc.32488.
    >> Share

    May 2019
  195. OROUJI E, Federico A, Larribere L, Novak D, et al
    Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target.
    Int J Cancer. 2019 May 27. doi: 10.1002/ijc.32432.
    >> Share

  196. GAO X, Wilsgaard T, Jansen EH, Xuan Y, et al
    Serum total thiol levels and the risk of lung, colorectal, breast and prostate cancer: A prospective case-cohort study.
    Int J Cancer. 2019 May 24. doi: 10.1002/ijc.32428.
    >> Share

  197. LI G, Xie Q, Yang Z, Wang L, et al
    Sp1-mediated epigenetic dysregulation dictates HDAC inhibitor susceptibility of HER2-overexpressing breast cancer.
    Int J Cancer. 2019 May 21. doi: 10.1002/ijc.32425.
    >> Share

  198. SHENG S, Xu Y, Guo Y, Yao L, et al
    Prevalence and Clinical Impact of TP53 Germline Mutations in Chinese Women with Breast Cancer.
    Int J Cancer. 2019 May 21. doi: 10.1002/ijc.32424.
    >> Share

  199. TRAPANI D, Rajasekar AKA, Mathew A
    More options for adjuvant treatment of HER2-positive breast cancer: How to choose wisely?
    Int J Cancer. 2019 May 20. doi: 10.1002/ijc.32418.
    >> Share

  200. JACOT W, Heudel PE, Fraisse J, Gourgou S, et al
    Real-life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program.
    Int J Cancer. 2019 May 14. doi: 10.1002/ijc.32402.
    >> Share

  201. KLEIBLOVA P, Stolarova L, Krizova K, Lhota F, et al
    Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer.
    Int J Cancer. 2019 May 3. doi: 10.1002/ijc.32385.
    >> Share

  202. BAO C, Yang R, Pedersen NL, Xu W, et al
    Overweight in midlife and risk of cancer in late life: A nationwide Swedish twin study.
    Int J Cancer. 2019;144:2128-2134.
    >> Share

  203. WU J, Crowe DL
    Molecular and cellular basis of mammary gland fibrosis and cancer risk.
    Int J Cancer. 2019;144:2239-2253.
    >> Share

    April 2019
  204. GE J, Liu H, Qian D, Wang X, et al
    Genetic variants of genes in the NER pathway associated with risk of breast cancer: a large-scale analysis of 14 published GWAS datasets in the DRIVE Study.
    Int J Cancer. 2019 Apr 26. doi: 10.1002/ijc.32371.
    >> Share

  205. FEKETE JT, Gyorffy B
    ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients.
    Int J Cancer. 2019 Apr 24. doi: 10.1002/ijc.32369.
    >> Share

  206. YEO HL, Fan TC, Lin RJ, Yu JC, et al
    Sialylation of vasorin by ST3Gal1 facilitates TGF-beta1-mediated tumor angiogenesis and progression.
    Int J Cancer. 2019;144:1996-2007.
    >> Share

  207. LIU LC, Wang YL, Lin PL, Zhang X, et al
    Long non-coding RNA HOTAIR promotes invasion of breast cancer cells through chondroitin sulfotransferase CHST15.
    Int J Cancer. 2019 Apr 9. doi: 10.1002/ijc.32319.
    >> Share

  208. ZUR HAUSEN H, Bund T, de Villiers EM
    Specific nutritional infections early in life as risk factors for human colon and breast cancers several decades later.
    Int J Cancer. 2019;144:1574-1583.
    >> Share

    March 2019
  209. VARGA Z, Sinn P, Seidman AD
    Comparing the performance of gene expression assays in breast cancer.
    Int J Cancer. 2019 Mar 20. doi: 10.1002/ijc.32289.
    >> Share

  210. SUTHERS GK
    Comparing the performance of gene expression assays in breast cancer.
    Int J Cancer. 2019 Mar 20. doi: 10.1002/ijc.32290.
    >> Share

  211. KIM EY, Chang Y, Lee KH, Yun JS, et al
    Serum concentration of thyroid hormones in abnormal and euthyroid ranges and breast cancer risk: A cohort study.
    Int J Cancer. 2019 Mar 18. doi: 10.1002/ijc.32283.
    >> Share

  212. COUSSY F, de Koning L, Lavigne M, Bernard V, et al
    A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancer.
    Int J Cancer. 2019 Mar 12. doi: 10.1002/ijc.32266.
    >> Share

  213. GIULIANELLI S, Riggio M, Guillardoy T, Perez Pinero C, et al
    FGF2 Induces Breast Cancer Growth through Ligand-Independent Activation and Recruitment of ERalpha and PRB4 Isoform to MYC Regulatory Sequences.
    Int J Cancer. 2019 Mar 7. doi: 10.1002/ijc.32252.
    >> Share

    February 2019
  214. ARRIAGA ME, Vajdic CM, Canfell K, MacInnis RJ, et al
    The preventable burden of breast cancers for premenopausal and postmenopausal women in Australia: a pooled cohort study.
    Int J Cancer. 2019 Feb 25. doi: 10.1002/ijc.32231.
    >> Share

  215. VERVER D, van der Veldt A, van Akkooi A, Verhoef C, et al
    Treatment of melanoma of unknown primary in the era of immunotherapy and targeted therapy: a Dutch population-based study.
    Int J Cancer. 2019 Feb 23. doi: 10.1002/ijc.32229.
    >> Share

  216. MIO C, Gerratana L, Bolis M, Caponnetto F, et al
    BET proteins regulate homologous recombination-mediated DNA repair: BRCAness and implications for cancer therapy.
    Int J Cancer. 2019;144:755-766.
    >> Share

  217. KIENY A, Cribier B, Meyer N, Velten M, et al
    Epidemiology of Merkel cell carcinoma. A population-based study from 1985 to 2013, in northeastern of France.
    Int J Cancer. 2019;144:741-745.
    >> Share

  218. ALTANEROVA U, Jakubechova J, Benejova K, Priscakova P, et al
    Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomes.
    Int J Cancer. 2019;144:897-908.
    >> Share

  219. MANDRIK O, Zielonke N, Meheus F, Severens JLH, et al
    Systematic reviews as a "lens of evidence": determinants of benefits and harms of breast cancer screening.
    Int J Cancer. 2019 Feb 14. doi: 10.1002/ijc.32211.
    >> Share

  220. DE KRUIJFF IE, Sieuwerts AM, Onstenk W, Jager A, et al
    Androgen receptor expression in circulating tumor cells of patients with metastatic breast cancer.
    Int J Cancer. 2019 Feb 13. doi: 10.1002/ijc.32209.
    >> Share

  221. VAN HELLEMOND IEG, Smorenburg CH, Peer PGM, Swinkels ACP, et al
    Assessment and Management of Bone Health in Women with Early Breast Cancer Receiving Endocrine Treatment in the DATA Study.
    Int J Cancer. 2019 Feb 12. doi: 10.1002/ijc.32205.
    >> Share

  222. DAI W, Liu H, Xu X, Jie G, et al
    Genetic variants in ELOVL2 and HSD17B12 predict melanoma-specific survival.
    Int J Cancer. 2019 Feb 8. doi: 10.1002/ijc.32194.
    >> Share

  223. ZEINOMAR N, Phillips KA, Daly MB, Milne RL, et al
    Benign Breast Disease Increases Breast Cancer Risk Independent of Underlying Familial Risk Profile: Findings from a Prospective Family Study Cohort (ProF-SC).
    Int J Cancer. 2019 Feb 6. doi: 10.1002/ijc.32112.
    >> Share

  224. SUN W, Xu X, Jiang Y, Jin X, et al
    Transcriptome analysis of Luminal Breast Cancer Reveals a Role for LOL in Tumor Progression and Tamoxifen Resistance.
    Int J Cancer. 2019 Feb 5. doi: 10.1002/ijc.32185.
    >> Share

    January 2019
  225. BHASKARAN SP, Chandratre K, Gupta H, Zhang L, et al
    Germline variation in BRCA1/2 is highly ethnic-specific: evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients.
    Int J Cancer. 2019 Jan 31. doi: 10.1002/ijc.32176.
    >> Share

  226. FRANKE V, Berger DMS, Klop WMC, van der Hiel B, et al
    High Response Rates for T-VEC in Early Metastatic Melanoma (Stage IIIB/C-IVM1a).
    Int J Cancer. 2019 Jan 29. doi: 10.1002/ijc.32172.
    >> Share

  227. CERVENKA I, Al Rahmoun M, Mahamat Saleh Y, Savoye I, et al
    Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study.
    Int J Cancer. 2019 Jan 22. doi: 10.1002/ijc.32150.
    >> Share

  228. CADENAS C, Vosbeck S, Edlund K, Grgas K, et al
    LIPG-promoted lipid storage mediates adaptation to oxidative stress in breast cancer.
    Int J Cancer. 2019 Jan 17. doi: 10.1002/ijc.32138.
    >> Share

  229. VARGA Z, Sinn P, Seidman AD
    Summary of head-to-head comparisons of patient risk classifications by the 21-gene Recurrence Score(R) (RS) assay and other genomic assays for early breast cancer.
    Int J Cancer. 2019 Jan 17. doi: 10.1002/ijc.32139.
    >> Share

  230. BRANDAO RD, Mensaert K, Lopez-Perolio I, Tserpelis D, et al
    Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes.
    Int J Cancer. 2019 Jan 8. doi: 10.1002/ijc.32114.
    >> Share

  231. RIZZOLO P, Zelli V, Silvestri V, Valentini V, et al
    Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy.
    Int J Cancer. 2019 Jan 7. doi: 10.1002/ijc.32106.
    >> Share

  232. CAHOON EK, Engels EA
    "Decreased incidence of Kaposi sarcoma after kidney transplant in Italy and role of mTOR-inhibitors: 1997-2016" Reply to Letter re: Risk of Kaposi sarcoma after solid organ transplantation in the United States.
    Int J Cancer. 2019 Jan 6. doi: 10.1002/ijc.32096.
    >> Share

  233. PISELLI P, Taborelli M, Cimaglia C, Serraino D, et al
    Decreased incidence of Kaposi sarcoma after kidney transplant in Italy and role of mTOR-inhibitors: 1997-2016.
    Int J Cancer. 2019 Jan 6. doi: 10.1002/ijc.32098.
    >> Share

    December 2018
  234. WEIDELE K, Stojanovic N, Feliciello G, Markiewicz A, et al
    Microfluidic enrichment, isolation and characterization of disseminated melanoma cells from lymph node samples.
    Int J Cancer. 2018 Dec 26. doi: 10.1002/ijc.32092.
    >> Share

  235. VAN HELLEMOND IEG, Vriens IJH, Peer PGM, Swinkels ACP, et al
    Efficacy of Anastrozole after Tamoxifen in Early Breast Cancer Patients with Chemotherapy-Induced Ovarian Function Failure.
    Int J Cancer. 2018 Dec 26. doi: 10.1002/ijc.32093.
    >> Share

  236. SUNG H, Guo C, Li E, Li J, et al
    The relationship between terminal duct lobular unit features and mammographic density among Chinese breast cancer patients.
    Int J Cancer. 2018 Dec 18. doi: 10.1002/ijc.32077.
    >> Share

  237. GUO D, Lui GYL, Lai SL, Wilmott JS, et al
    RAB27A promotes melanoma cell invasion and metastasis via regulation of pro-invasive exosomes.
    Int J Cancer. 2018 Dec 17. doi: 10.1002/ijc.32064.
    >> Share

  238. POLLOM EL, Qian Y, Chin AL, Dirbas FM, et al
    Rising rates of bilateral mastectomy with reconstruction following neoadjuvant chemotherapy.
    Int J Cancer. 2018;143:3262-3272.
    >> Share

  239. HAMERS FF, Assogba FAG, Rogel A
    Implementation and organization of cancer screening in France.
    Int J Cancer. 2018;143:3281.
    >> Share

  240. GRIONI S, Agnoli C, Krogh V, Pala V, et al
    Dietary cadmium and risk of breast cancer subtypes defined by hormone receptor status: a prospective cohort study.
    Int J Cancer. 2018 Dec 4. doi: 10.1002/ijc.32039.
    >> Share

  241. GRAF ME, Sookthai D, Johnson T, Schubel R, et al
    Pre-diagnostic plasma concentrations of Fibrinogen, sGPIIb/IIIa, sP-selectin, sThrombomodulin, Thrombopoietin in relation to cancer risk: Findings from a large prospective study.
    Int J Cancer. 2018;143:2659-2667.
    >> Share

  242. MIGLIO U, Berrino E, Panero M, Ferrero G, et al
    The expression of LINE1-MET chimeric transcript identifies a subgroup of aggressive breast cancers.
    Int J Cancer. 2018;143:2838-2848.
    >> Share

    November 2018
  243. TORRES D, Lorenzo Bermejo J, Garcia Mesa K, Gilbert M, et al
    Interaction between genetic ancestry and common breast cancer susceptibility variants in Colombian women.
    Int J Cancer. 2018 Nov 28. doi: 10.1002/ijc.32023.
    >> Share

  244. KLASCHIK K, Hauke J, Neidhardt G, Trankle C, et al
    The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers.
    Int J Cancer. 2018 Nov 26. doi: 10.1002/ijc.32016.
    >> Share

  245. BULANOVA DR, Helenius M, Sokolenko AP, Kuznetsov SG, et al
    Response to: The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers.
    Int J Cancer. 2018 Nov 25. doi: 10.1002/ijc.32013.
    >> Share

  246. PEREIRA-VEIGA T, Abreu M, Robledo D, Matias-Guiu X, et al
    CTCs-derived xenograft development in a Triple Negative breast cancer case.
    Int J Cancer. 2018 Nov 19. doi: 10.1002/ijc.32001.
    >> Share

  247. RUEEGG CS, Stenehjem JS, Egger M, Ghiasvand R, et al
    Challenges in Assessing the Sunscreen-Melanoma Association.
    Int J Cancer. 2018 Nov 16. doi: 10.1002/ijc.31997.
    >> Share

  248. SROUR B, Plancoulaine S, Andreeva VA, Fassier P, et al
    Circadian nutritional behaviours and cancer risk: New insights from the NutriNet-sante prospective cohort study: Disclaimers.
    Int J Cancer. 2018;143:2369-2379.
    >> Share

  249. SCHUBERT S, van Luttikhuizen JL, Auber B, Schmidt G, et al
    The identification of pathogenic variants in BRCA1/2 negative, high risk, hereditary breast and/or ovarian cancer patients: high frequency of FANCM pathogenic variants.
    Int J Cancer. 2018 Nov 13. doi: 10.1002/ijc.31992.
    >> Share

  250. YUAN B, Schafferer S, Tang Q, Scheffler M, et al
    A plasma metabolite panel as biomarkers for early primary breast cancer detection.
    Int J Cancer. 2018 Nov 13. doi: 10.1002/ijc.31996.
    >> Share

  251. POTJER TP, Bollen S, Grimbergen AJEM, van Doorn R, et al
    Multi-gene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non-CDKN2A/CDK4 melanoma families.
    Int J Cancer. 2018 Nov 10. doi: 10.1002/ijc.31984.
    >> Share

  252. ASLEH K, Lyck Carstensen S, Tykjaer Jorgensen CL, Burugu S, et al
    Basal biomarkers Nestin and INPP4B predict gemcitabine benefit in metastatic breast cancer: samples from the phase III SBG0102 clinical trial.
    Int J Cancer. 2018 Nov 9. doi: 10.1002/ijc.31969.
    >> Share

  253. MINICOZZI P, Van Eycken L, Molinie F, Innos K, et al
    Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer.
    Int J Cancer. 2018 Nov 8. doi: 10.1002/ijc.31974.
    >> Share

    October 2018
  254. VAN MAAREN MC, de Munck L, Strobbe LJ, Sonke GS, et al
    10-year recurrence rates for breast cancer subtypes in the Netherlands: A large population-based study.
    Int J Cancer. 2018 Oct 28. doi: 10.1002/ijc.31914.
    >> Share

  255. SUN L, Sadique Z, Dos-Santos-Silva I, Yang L, et al
    Cost-effectiveness of Breast Cancer Screening Programme for Women in Rural China.
    Int J Cancer. 2018 Oct 27. doi: 10.1002/ijc.31956.
    >> Share

  256. JOHANSSON ALV, Trewin CB, Hjerkind KV, Ellingjord-Dale M, et al
    Breast cancer-specific survival by clinical subtype after seven years follow-up of young and elderly women in a nationwide cohort.
    Int J Cancer. 2018 Oct 26. doi: 10.1002/ijc.31950.
    >> Share

  257. BENS A, Cronin-Fenton D, Dehlendorff C, Jensen MB, et al
    Non-aspirin NSAIDs and contralateral breast cancer risk.
    Int J Cancer. 2018 Oct 26. doi: 10.1002/ijc.31949.
    >> Share

  258. HOUGHTON SC, Eliassen AH, Zhang SM, Selhub J, et al
    Plasma B-vitamin and one-carbon metabolites and risk of breast cancer before and after folic acid fortification in the US.
    Int J Cancer. 2018 Oct 22. doi: 10.1002/ijc.31934.
    >> Share

  259. GIRARD E, Eon-Marchais S, Olaso R, Renault AL, et al
    Familial breast cancer and DNA repair genes: insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing.
    Int J Cancer. 2018 Oct 10. doi: 10.1002/ijc.31921.
    >> Share

  260. BERRANDOU T, Mulot C, Cordina-Duverger E, Arveux P, et al
    Association of breast cancer risk with polymorphisms in genes involved in the metabolism of xenobiotics and interaction with tobacco smoking: a gene-set analysis.
    Int J Cancer. 2018 Oct 10. doi: 10.1002/ijc.31917.
    >> Share

  261. SHEN Y, Zhang W, Liu J, He J, et al
    Therapeutic Activity of DCC-2036, a Novel Tyrosine Kinase Inhibitor, against Triple-Negative Breast Cancer Patient-Derived Xenografts by Targeting AXL/MET.
    Int J Cancer. 2018 Oct 5. doi: 10.1002/ijc.31915.
    >> Share

  262. LATTOUF H, Kassem L, Jacquemetton J, Choucair A, et al
    LKB1 regulates PRMT5 activity in breast cancer.
    Int J Cancer. 2018 Oct 5. doi: 10.1002/ijc.31909.
    >> Share

    September 2018
  263. HARDING C, Pompei F, Burmistrov D, Wilson R, et al
    Long-term relationships between screening rates, breast cancer characteristics, and overdiagnosis in US counties, 1975-2009.
    Int J Cancer. 2018 Sep 28. doi: 10.1002/ijc.31904.
    >> Share

  264. JI J, Sundquist J, Sundquist K
    Use of terbinafine and risk of death in patients with prostate cancer: A population-based cohort study.
    Int J Cancer. 2018 Sep 27. doi: 10.1002/ijc.31901.
    >> Share

  265. ELANDS RJ, Offermans NS, Simons CC, Schouten LJ, et al
    Associations of adult-attained height and early life energy restriction with postmenopausal breast cancer risk according to estrogen and progesterone receptor status.
    Int J Cancer. 2018 Sep 25. doi: 10.1002/ijc.31890.
    >> Share

  266. PARK YM, Steck SE, Fung TT, Merchant AT, et al
    Higher diet-dependent acid load is associated with risk of breast cancer: Findings from the Sister Study.
    Int J Cancer. 2018 Sep 24. doi: 10.1002/ijc.31889.
    >> Share

  267. DASSLER-PLENKER J, Paschen A, Putschli B, Rattay S, et al
    Direct RIG-I activation in human NK cells induces TRAIL-dependent cytotoxicity towards autologous melanoma cells.
    Int J Cancer. 2018 Sep 19. doi: 10.1002/ijc.31874.
    >> Share

  268. STROHSNITTER WC, Bertrand KA, Troisi R, Scott CG, et al
    Prenatal diethylstilbestrol exposure and mammographic density.
    Int J Cancer. 2018;143:1374-1378.
    >> Share

  269. LIN MC, Chen SY, He PL, Herschman H, et al
    PGE2 /EP4 antagonism enhances tumor chemosensitivity by inducing extracellular vesicle-mediated clearance of cancer stem cells.
    Int J Cancer. 2018;143:1440-1455.
    >> Share

  270. EL-MALLAWANY NK, Mehta PS, Kamiyango W, Villiera J, et al
    KSHV Viral Load and Interleukin-6 in HIV-Associated Pediatric Kaposi Sarcoma-Exploring the Role of Lytic Activation in Driving the Unique Clinical Features Seen in Endemic Regions.
    Int J Cancer. 2018 Sep 11. doi: 10.1002/ijc.31863.
    >> Share

  271. HAM SA, Kim E, Yoo T, Lee WJ, et al
    Ligand-activated interaction of PPARdelta with c-Myc governs the tumorigenicity of breast cancer.
    Int J Cancer. 2018 Sep 11. doi: 10.1002/ijc.31864.
    >> Share

  272. KOMEMI O, Epstein Shochet G, Pomeranz M, Fishman A, et al
    Placenta-conditioned extracellular matrix (ECM) activates breast cancer cell survival mechanisms: A key for future distant metastases.
    Int J Cancer. 2018 Sep 8. doi: 10.1002/ijc.31861.
    >> Share

  273. BRADBURY KE, Appleby PN, Tipper SJ, Travis RC, et al
    Circulating insulin-like growth factor I in relation to melanoma risk in the European Prospective Investigation into Cancer and Nutrition.
    Int J Cancer. 2018 Sep 7. doi: 10.1002/ijc.31854.
    >> Share

  274. JIN ML, Kim YW, Jin HL, Kang H, et al
    Aberrant expression of SETD1A promotes survival and migration of estrogen receptor alpha-positive breast cancer cells.
    Int J Cancer. 2018 Sep 7. doi: 10.1002/ijc.31853.
    >> Share

  275. FARVID MS, Stern MC, Norat T, Sasazuki S, et al
    Consumption of red and processed meat and breast cancer incidence: a systematic review and meta-analysis of prospective studies.
    Int J Cancer. 2018 Sep 5. doi: 10.1002/ijc.31848.
    >> Share

  276. FALK RT, Manson JE, Barnabei VM, Anderson GL, et al
    Estrogen metabolism in menopausal hormone users in the Women's Health Initiative Observational Study: Does it differ between estrogen plus progestin and estrogen alone?
    Int J Cancer. 2018 Sep 5. doi: 10.1002/ijc.31851.
    >> Share

  277. WILMOTT JS, Johansson PA, Newell F, Waddell N, et al
    Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility.
    Int J Cancer. 2018 Sep 4. doi: 10.1002/ijc.31791.
    >> Share

  278. LI J, Wen WX, Eklund M, Kvist A, et al
    Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort.
    Int J Cancer. 2018 Sep 2. doi: 10.1002/ijc.31841.
    >> Share

    August 2018
  279. YE L, Li F, Song Y, Yu D, et al
    Overexpression of CDCA7 predicts poor prognosis and induces EZH2-mediated progression of Triple-Negative Breast Cancer.
    Int J Cancer. 2018 Aug 27. doi: 10.1002/ijc.31766.
    >> Share

  280. MOLLER MH, Lousdal ML, Kristiansen IS, Stovring H, et al
    Effect of organised mammography screening on breast cancer mortality: A population-based cohort study in Norway.
    Int J Cancer. 2018 Aug 25. doi: 10.1002/ijc.31832.
    >> Share

  281. ZHAO B, Zhao H, Zhao J
    Impact of clinicopathological characteristics on survival in patients treated with immune checkpoint inhibitors for metastatic melanoma.
    Int J Cancer. 2018 Aug 19. doi: 10.1002/ijc.31813.
    >> Share

  282. GAUDET MM, Deubler EL, Kelly RS, Diver WR, et al
    Blood Levels of Cadmium and Lead in Relation to Breast Cancer Risk in Three Prospective Cohorts.
    Int J Cancer. 2018 Aug 17. doi: 10.1002/ijc.31805.
    >> Share

  283. WU H, Larribere L, Sun Q, Novak D, et al
    Loss of neural crest-associated gene FOXD1 impairs melanoma invasion and migration via RAC1B downregulation.
    Int J Cancer. 2018 Aug 15. doi: 10.1002/ijc.31799.
    >> Share

  284. MC MENAMIN UC, Kunzmann AT, Cook MB, Johnston BT, et al
    Hormonal and reproductive factors and risk of upper gastrointestinal cancers in men: A prospective cohort study within the UK Biobank.
    Int J Cancer. 2018;143:831-841.
    >> Share

  285. KIVES Z, Juhasz K, Csakvari T, Agoston I, et al
    Cancer screening policy in Hungary.
    Int J Cancer. 2018;143:1003-1004.
    >> Share

  286. PEDERSEN MH, Hood BL, Ehmsen S, Beck HC, et al
    CYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patients.
    Int J Cancer. 2018 Aug 15. doi: 10.1002/ijc.31798.
    >> Share

  287. SHARBI-YUNGER A, Grees M, Gal C, Bassan D, et al
    A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival.
    Int J Cancer. 2018 Aug 14. doi: 10.1002/ijc.31795.
    >> Share

  288. LEE WH, Chen LC, Lee CJ, Huang CC, et al
    DNA primase polypeptide 1 (PRIM1) involves in estrogen-induced breast cancer formation through activation of the G2/M cell cycle checkpoint.
    Int J Cancer. 2018 Aug 11. doi: 10.1002/ijc.31788.
    >> Share

  289. CORTESI L, Canossi B, Battista R, Pecchi A, et al
    Breast ultrasonography in the screening protocol for women at hereditary- familial risk of breast cancer: Has the time come to rethink the role of BU according to different risk categories?
    Int J Cancer. 2018 Aug 11. doi: 10.1002/ijc.31794.
    >> Share

  290. ANDRES-LENCINA JJ, Rachakonda S, Garcia-Casado Z, Srinivas N, et al
    TERT promoter mutation subtypes and survival in stage I and II melanoma patients.
    Int J Cancer. 2018 Aug 2. doi: 10.1002/ijc.31780.
    >> Share

  291. CHUANG SC, Lin CH, Lu YS, Hsiung CA, et al
    Association of pregnancy and mortality in women diagnosed with breast cancer: A nationwide population based study in Taiwan.
    Int J Cancer. 2018 Aug 2. doi: 10.1002/ijc.31777.
    >> Share

  292. KWOK ZH, Roche V, Chew XH, Fadieieva A, et al
    A non-canonical tumor suppressive role for the long non-coding RNA MALAT1 in colon and breast cancers.
    Int J Cancer. 2018;143:668-678.
    >> Share

  293. OH H, Pfeiffer RM, Falk RT, Horne HN, et al
    Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank.
    Int J Cancer. 2018;143:496-507.
    >> Share

    July 2018
  294. KOGEVINAS M, Espinosa A, Castello A, Gomez-Acebo I, et al
    Effect of mistimed eating patterns on breast and prostate cancer risk (MCC-Spain Study).
    Int J Cancer. 2018 Jul 17. doi: 10.1002/ijc.31649.
    >> Share

  295. ANDREE KC, Mentink A, Zeune LL, Terstappen LWMM, et al
    Towards a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multi-center study (CTCTrap).
    Int J Cancer. 2018 Jul 14. doi: 10.1002/ijc.31752.
    >> Share

  296. BASU P, Selmouni F, Belakhel L, Sauvaget C, et al
    Breast Cancer Screening Program in Morocco: Status of implementation, organization and performance.
    Int J Cancer. 2018 Jul 14. doi: 10.1002/ijc.31749.
    >> Share

  297. IZRAELY S, Ben-Menachem S, Sagi-Assif O, Telerman A, et al
    The Metastatic Microenvironment: Melanoma-Microglia Cross-Talk Promotes the Malignant Phenotype of Melanoma Cells.
    Int J Cancer. 2018 Jul 11. doi: 10.1002/ijc.31745.
    >> Share

  298. MCCORMACK V, Febvey-Combes O, Ginsburg O, Dos-Santos-Silva I, et al
    Breast cancer in women living with HIV: A first global estimate.
    Int J Cancer. 2018 Jul 11. doi: 10.1002/ijc.31722.
    >> Share

  299. CLENDENEN TV, Dorgan J, Zeleniuch-Jacquotte A
    Reply to: Anti-Mullerian hormone and breast cancer risk- is the correlation possibly associated with the PCOS?
    Int J Cancer. 2018 Jul 11. doi: 10.1002/ijc.31728.
    >> Share

  300. TESCH H, Stoetzer O, Decker T, Kurbacher CM, et al
    Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial
    Int J Cancer. 2018 Jul 11. doi: 10.1002/ijc.31738.
    >> Share

  301. CAHOON EK, Linet MS, Clarke CA, Pawlish KS, et al
    Risk of Kaposi sarcoma after solid organ transplantation in the United States.
    Int J Cancer. 2018 Jul 10. doi: 10.1002/ijc.31735.
    >> Share

  302. STERNBERG C, Gruber W, Eberl M, Tesanovic S, et al
    Synergistic Cross-Talk of Hedgehog and Interleukin-6 Signaling Drives Growth of Basal Cell Carcinoma.
    Int J Cancer. 2018 Jul 10. doi: 10.1002/ijc.31724.
    >> Share

  303. BLUMENFELD Z
    Anti-Mullerian hormone and breast cancer risk- is the correlation possibly associated with the PCOS?
    Int J Cancer. 2018 Jul 10. doi: 10.1002/ijc.31732.
    >> Share

  304. YANG CC, Chang CK, Chang MT, Shyur LF, et al
    Plant galactolipid dLGG suppresses lung metastasis of melanoma through deregulating TNF-alpha-mediated pulmonary vascular permeability and circulating oxylipin dynamics in mice.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31663.
    >> Share

  305. CERVENKA I, Mahamat-Saleh Y, Savoye I, Dartois L, et al
    Oral contraceptive use and cutaneous melanoma risk: A french prospective cohort study.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31644.
    >> Share

  306. LAN B, Ma F, Chen S, Wang W, et al
    Toremifene, rather than tamoxifen, might be a better option for the adjuvant endocrine therapy in CYP2D6*10 T/T genotype breast cancer patients in China.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31639.
    >> Share

  307. PARK YH, Lee KH, Sohn JH, Lee KS, et al
    A phase II trial of the pan-HER inhibitor poziotinib, in patients with HER2-positive metastatic breast cancer who had received at least two prior HER2-directed regimens: results of the NOV120101-203 trial.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31651.
    >> Share

  308. VANGANGELT KMH, Tollenaar LSA, van Pelt GW, de Kruijf EM, et al
    The prognostic value of tumor-stroma ratio in tumor-positive axillary lymph nodes of breast cancer patients.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31658.
    >> Share

  309. SALEM Y, Yacov N, Propheta-Meiran O, Breitbart E, et al
    Newly Characterized Motile Sperm Domain-Containing Protein 2 Promotes Human Breast Cancer Metastasis.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31665.
    >> Share

  310. JASKULSKI S, Jung AY, Behrens S, Johnson T, et al
    Circulating enterolactone concentrations and prognosis of postmenopausal breast cancer: Assessment of mediation by inflammatory markers.
    Int J Cancer. 2018 Jul 4. doi: 10.1002/ijc.31647.
    >> Share

  311. KISO M, Tanaka S, Saji S, Toi M, et al
    Long isoform of VEGF stimulates cell migration of breast cancer by filopodia formation via NRP1/ARHGAP17/Cdc42 regulatory network.
    Int J Cancer. 2018 Jul 4. doi: 10.1002/ijc.31645.
    >> Share

  312. TAN J, Fu L, Chen H, Guan J, et al
    Association study of genetic variation in the autophagy lysosome pathway genes and risk of eight kinds of cancers.
    Int J Cancer. 2018;143:80-87.
    >> Share

    June 2018
  313. HUSER L, Sachindra, Granados K, Federico A, et al
    SOX2-mediated upregulation of CD24 promotes adaptive resistance towards targeted therapy in melanoma.
    Int J Cancer. 2018 Jun 15. doi: 10.1002/ijc.31609.
    >> Share

    May 2018
  314. WU W, Chen F, Cui X, Yang L, et al
    LncRNA NKILA Suppresses TGF-beta-induced Epithelial-Mesenchymal Transition by Blocking NF-kappaB Signaling in Breast Cancer.
    Int J Cancer. 2018 May 15. doi: 10.1002/ijc.31605.
    >> Share

  315. LA MANNA S, Lee E, Ouzounova M, Di Natale C, et al
    Mimetics of Suppressor of cytokine signalling 3: novel potential therapeutics in triple breast cancer.
    Int J Cancer. 2018 May 11. doi: 10.1002/ijc.31594.
    >> Share

  316. XIE J, Shen K, Lenchine RV, Gethings LA, et al
    Eukaryotic elongation factor 2 kinase upregulates the expression of proteins implicated in cell migration and cancer cell metastasis.
    Int J Cancer. 2018;142:1865-1877.
    >> Share

    April 2018
  317. LI J, Wang W, Xia P, Wan L, et al
    Identification of a five-lncRNA signature for predicting the risk of tumor recurrence in breast cancer patients.
    Int J Cancer. 2018 Apr 29. doi: 10.1002/ijc.31573.
    >> Share

  318. AL-AWADHI A, Murray JL, Ibrahim NK
    Developing Anti-HER2 Vaccines: Breast Cancer Experience.
    Int J Cancer. 2018 Apr 25. doi: 10.1002/ijc.31551.
    >> Share

  319. ARNOLD M, de Vries E, Whiteman DC, Jemal A, et al
    Global burden of cutaneous melanoma attributable to ultraviolet radiation in 2012.
    Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31527.
    >> Share

  320. WILKE CM, Braselmann H, Hess J, Klymenko SV, et al
    A genomic copy number signature predicts radiation exposure in post-Chernobyl breast cancer.
    Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31533.
    >> Share

  321. BOCK J, Appenzeller S, Haertle L, Schneider T, et al
    Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.
    Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31526.
    >> Share

  322. SHAFIEE A, McGovern JA, Lahr CA, Meinert C, et al
    Immune System Augmentation via Humanization Using Stem/Progenitor Cells and Bioengineering in a Breast Cancer Model Study.
    Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31528.
    >> Share

  323. CAO C, Wu H, Vasilatos SN, Chandran U, et al
    HDAC5-LSD1 Axis Regulates Antineoplastic Effect of Natural HDAC Inhibitor Sulforaphane in Human Breast Cancer Cells.
    Int J Cancer. 2018 Apr 6. doi: 10.1002/ijc.31419.
    >> Share

  324. NJOR SH, Paci E, Rebolj M
    As you like it: How the same data can support manifold views of overdiagnosis in breast cancer screening.
    Int J Cancer. 2018 Apr 6. doi: 10.1002/ijc.31420.
    >> Share

    March 2018
  325. ERIKSSON L, Bergh J, Humphreys K, Warnberg F, et al
    Time from breast cancer diagnosis to therapeutic surgery and breast cancer prognosis: A population-based cohort study.
    Int J Cancer. 2018 Mar 31. doi: 10.1002/ijc.31411.
    >> Share

  326. GUINTER MA, McLain AC, Merchant AT, Sandler DP, et al
    A dietary pattern based on estrogen metabolism is associated with breast cancer risk in a prospective cohort of postmenopausal women.
    Int J Cancer. 2018 Mar 25. doi: 10.1002/ijc.31387.
    >> Share

  327. DE MUNCK L, Fracheboud J, de Bock GH, den Heeten GJ, et al
    Is the incidence of advanced-stage breast cancer affected by whether women attend a steady-state screening program?
    Int J Cancer. 2018 Mar 25. doi: 10.1002/ijc.31388.
    >> Share

  328. GUO W, Key TJ, Reeves GK
    Adiposity and breast cancer risk in postmenopausal women: Results from the UK Biobank prospective cohort.
    Int J Cancer. 2018 Mar 23. doi: 10.1002/ijc.31394.
    >> Share

  329. WEI F, Li M, Wu X, Yin K, et al
    The prevalence and concordance of human papillomavirus infection in different anogenital sites among men and women in Liuzhou, China: A population-based study.
    Int J Cancer. 2018;142:1244-1251.
    >> Share

  330. WRIGHT LB, Schoemaker MJ, Jones ME, Ashworth A, et al
    Breast cancer risk in relation to history of preeclampsia and hyperemesis gravidarum: Prospective analysis in the Generations Study.
    Int J Cancer. 2018 Mar 8. doi: 10.1002/ijc.31364.
    >> Share

  331. ABUBAKAR M, Chang-Claude J, Ali HR, Chatterjee N, et al
    Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation.
    Int J Cancer. 2018 Mar 1. doi: 10.1002/ijc.31352.
    >> Share

    February 2018
  332. CZARNECKI D
    Immigration is the most likely reason for the generational change in melanoma incidence in Queensland, Australia.
    Int J Cancer. 2018 Feb 28. doi: 10.1002/ijc.31348.
    >> Share

  333. AITKEN JF, Youlden DR, Baade PD, Soyer HP, et al
    In response to: Immigration is the most likely reason for the generational change in melanoma incidence in Queensland, Australia.
    Int J Cancer. 2018 Feb 28. doi: 10.1002/ijc.31347.
    >> Share

  334. LIYANAGE UE, Law MH, Ong JS, Cust AE, et al
    Polyunsaturated fatty acids and risk of melanoma: A Mendelian randomisation analysis.
    Int J Cancer. 2018 Feb 22. doi: 10.1002/ijc.31334.
    >> Share

  335. TER VEER E, Creemers A, de Waal L, van Oijen MGH, et al
    Comparing cytotoxic backbones for first-line trastuzumab-containing regimens in HER2-positive advanced esophagogastric cancer: A meta-analysis.
    Int J Cancer. 2018 Feb 16. doi: 10.1002/ijc.31325.
    >> Share

  336. LAN B, Ma F, Zhai X, Li Q, et al
    The relationship between the CYP2D6 polymorphisms and tamoxifen efficacy in adjuvant endocrine therapy of breast cancer patients in Chinese Han population.
    Int J Cancer. 2018 Feb 3. doi: 10.1002/ijc.31291.
    >> Share

    January 2018
  337. SETTE G, Salvati V, Giordani I, Pillozzi E, et al
    Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells.
    Int J Cancer. 2018 Jan 17. doi: 10.1002/ijc.31260.
    >> Share

  338. BEGG CB, Ostrovnaya I, Geyer FC, Papanastasiou AD, et al
    Contralateral breast cancers: Independent cancers or metastases?
    Int J Cancer. 2018;142:347-356.
    >> Share

  339. LI B, Wang Y, Xu Y, Liu H, et al
    Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival.
    Int J Cancer. 2018 Jan 4. doi: 10.1002/ijc.31243.
    >> Share

  340. BASU P, Ponti A, Anttila A, Ronco G, et al
    Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report.
    Int J Cancer. 2018;142:44-56.
    >> Share

    December 2017
  341. ANDERSON C, Engel SM, Anders CK, Nichols HB, et al
    Live birth outcomes after adolescent and young adult breast cancer.
    Int J Cancer. 2017 Dec 21. doi: 10.1002/ijc.31227.
    >> Share

  342. MARTIN CA, Cullinane C, Kirby L, Abuhammad S, et al
    Palbociclib synergizes with BRAF and MEK inhibitors in treatment naive melanoma but not after the development of BRAF inhibitor resistance.
    Int J Cancer. 2017 Dec 15. doi: 10.1002/ijc.31220.
    >> Share

  343. CHEN J, Yao Q, Huang M, Wang B, et al
    A Randomized Phase III Trial of Neoadjuvant Recombinant Human Endostatin, Docetaxel and Epirubicin as First-Line Therapy for Patients with Breast Cancer (CBCRT01).
    Int J Cancer. 2017 Dec 14. doi: 10.1002/ijc.31217.
    >> Share

  344. XIE X, Tan W, Chen B, Huang X, et al
    Preoperative prediction nomogram based on primary tumor miRNAs signature and clinical-related features for axillary lymph node metastasis in early-stage invasive breast cancer.
    Int J Cancer. 2017 Dec 11. doi: 10.1002/ijc.31208.
    >> Share

  345. MA L, Fu Q, Xu B, Zhou H, et al
    Breast cancer-associated mitochondrial DNA haplogroup promotes neoplastic growth via ROS-mediated AKT activation.
    Int J Cancer. 2017 Dec 11. doi: 10.1002/ijc.31207.
    >> Share

  346. GALLAGHER SJ, Gunatilake D, Beaumont KA, Sharp DM, et al
    HDAC inhibitors restore BRAF-inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma.
    Int J Cancer. 2017 Dec 6. doi: 10.1002/ijc.31199.
    >> Share

  347. HUANG L, Qin Y, Zuo Q, Bhatnagar K, et al
    Ezrin mediates both HGF/Met autocrine and non-autocrine signaling-induced metastasis in melanoma.
    Int J Cancer. 2017 Dec 6. doi: 10.1002/ijc.31196.
    >> Share

  348. UGGE H, Udumyan R, Carlsson J, Andren O, et al
    Acne in late adolescence and risk of prostate cancer.
    Int J Cancer. 2017 Dec 4. doi: 10.1002/ijc.31192.
    >> Share

  349. DALLASPEZIA S, Cantamessa S, Benedetti F
    Light Therapy and Mood in Breast Cancer.
    Int J Cancer. 2017 Dec 2. doi: 10.1002/ijc.31188.
    >> Share

  350. MCKENZIE F, Zietsman A, Galukande M, Anele A, et al
    Drivers of advanced stage at breast cancer diagnosis in the multi-country African Breast Cancer - Disparities in Outcomes (ABC-DO) study.
    Int J Cancer. 2017 Dec 2. doi: 10.1002/ijc.31187.
    >> Share

    November 2017
  351. LEE KR, Hwang IC, Do Han K, Jung J, et al
    Waist circumference and risk of breast cancer in Korean women: A nationwide cohort study.
    Int J Cancer. 2017 Nov 29. doi: 10.1002/ijc.31180.
    >> Share

  352. HIS M, Le Guelennec M, Mesrine S, Boutron-Ruault MC, et al
    Life course evolution of body size and breast cancer survival in the E3N cohort.
    Int J Cancer. 2017 Nov 27. doi: 10.1002/ijc.31177.
    >> Share

  353. CHEN ST, Li X, Han J
    Personal history of non-melanoma skin cancer diagnosis and death from melanoma in women.
    Int J Cancer. 2017 Nov 24. doi: 10.1002/ijc.31176.
    >> Share

  354. JOHANSSON ALV, Andersson TM, Hsieh CC, Jirstrom K, et al
    Tumor characteristics and prognosis in women with pregnancy-associated breast cancer.
    Int J Cancer. 2017 Nov 23. doi: 10.1002/ijc.31174.
    >> Share

  355. BOADA A, Tejera-Vaquerizo A, Ribero S, Puig S, et al
    Reply to prognosis of sentinel lymph node biopsy in patients with thick melanoma by a propensity score matching prospective study.
    Int J Cancer. 2017 Nov 20. doi: 10.1002/ijc.31162.
    >> Share

  356. KAWADA T
    Prognosis of sentinel lymph node biopsy in patients with thick melanoma by a propensity score matching prospective study.
    Int J Cancer. 2017 Nov 18. doi: 10.1002/ijc.31163.
    >> Share

  357. SCHAIRER C, Pfeiffer RM, Gadalla SM
    Autoimmune diseases and breast cancer risk by tumor hormone-receptor status among elderly women.
    Int J Cancer. 2017 Nov 16. doi: 10.1002/ijc.31148.
    >> Share

  358. BRANDT J, Borgquist S, Almgren P, Forsti A, et al
    Thyroid associated genetic polymorphisms in relation to breast cancer risk in the Malmo Diet and Cancer Study.
    Int J Cancer. 2017 Nov 14. doi: 10.1002/ijc.31156.
    >> Share

  359. WANG Y, Pfeiffer RM, Alsaggaf R, Meeraus W, et al
    Risk of skin cancer among patients with myotonic dystrophy type 1 based on Primary care physician data from the United Kingdom Clinical Practice Research Datalink.
    Int J Cancer. 2017 Nov 7. doi: 10.1002/ijc.31143.
    >> Share

  360. BARRDAHL M, Canzian F, Gaudet MM, Gapstur SM, et al
    A comprehensive analysis of polymorphic variants in steroid hormone and IGF-1 metabolism and risk of in situ breast cancer: results from the Breast and Prostate Cancer Cohort (BPC3) Consortium.
    Int J Cancer. 2017 Nov 7. doi: 10.1002/ijc.31145.
    >> Share

  361. AITKEN JF, Youlden DR, Baade PD, Soyer HP, et al
    Generational shift in melanoma incidence and mortality in Queensland, Australia, 1995-2014.
    Int J Cancer. 2017 Nov 6. doi: 10.1002/ijc.31141.
    >> Share

    October 2017
  362. SCHMIDT ME, Wiskemann J, Schneeweiss A, Potthoff K, et al
    Determinants of physical, affective, and cognitive fatigue: During breast cancer therapy and 12 months follow-up.
    Int J Cancer. 2017 Oct 30. doi: 10.1002/ijc.31138.
    >> Share

  363. HIRKO KA, Chai B, Spiegelman D, Campos H, et al
    Erythrocyte membrane fatty acids and breast cancer risk: A prospective analysis in the Nurses' Health Study II.
    Int J Cancer. 2017 Oct 26. doi: 10.1002/ijc.31133.
    >> Share

  364. KEINAN-BOKER L, Levine H, Leiba A, Derazne E, et al
    Adolescent obesity and adult male breast cancer in a cohort of 1,382,093 men.
    Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31121.
    >> Share

  365. YU J, Wang X, Lu Q, Wang J, et al
    Extracellular 5'-nucleotidase (CD73) promotes human breast cancer cells growth through AKT/GSK-3beta/beta-catenin/cyclinD1 signaling pathway.
    Int J Cancer. 2017 Oct 19. doi: 10.1002/ijc.31112.
    >> Share

  366. SUROWY H, Varga D, Burwinkel B, Marme F, et al
    A low frequency haplotype spanning SLX4/FANCP constitutes a new risk locus for early-onset breast cancer (<60 years) and is associated with reduced DNA repair capacity.
    Int J Cancer. 2017 Oct 16. doi: 10.1002/ijc.31105.
    >> Share

  367. JACKLYN G, Howard K, Irwig L, Houssami N, et al
    Impact of extending screening mammography to older women Information to support informed choices.
    Int J Cancer. 2017;141:1540-1550.
    >> Share

  368. ZHAO B, Zhao H
    Impact of clinicopathological characteristics on the efficacy of neoadjuvant therapy in patients with human epidermal growth factor receptor-2-positive breast cancer.
    Int J Cancer. 2017 Oct 11. doi: 10.1002/ijc.31097.
    >> Share

  369. CONRAD C, Gotte M, Schlomann U, Roessler M, et al
    ADAM8 expression in breast cancer derived metastases: Functional implications on MMP-9 expression and transendothelial migration in breast cancer cells.
    Int J Cancer. 2017 Oct 7. doi: 10.1002/ijc.31090.
    >> Share

  370. STENEHJEM JS, Veierod MB, Nilsen LT, Ghiasvand R, et al
    Anthropometric factors and cutaneous melanoma: Prospective data from the population-based Janus Cohort.
    Int J Cancer. 2017 Oct 6. doi: 10.1002/ijc.31086.
    >> Share

  371. NAGAPRASHANTHA LD, Adhikari R, Singhal J, Chikara S, et al
    Translational Opportunities for Broad-Spectrum Natural Phytochemicals and Targeted Agent Combinations in Breast Cancer.
    Int J Cancer. 2017 Oct 4. doi: 10.1002/ijc.31085.
    >> Share

  372. PAN R, Zhu M, Yu C, Lv J, et al
    Cancer incidence and mortality: A cohort study in China, 2008-2013.
    Int J Cancer. 2017;141:1315-1323.
    >> Share

    September 2017
  373. BOADA A, Tejera-Vaquerizo A, Ribero S, Puig S, et al
    Sentinel Lymph Node Biopsy vs Observation in Thick Melanoma: A Multicenter Propensity Score Matching Study.
    Int J Cancer. 2017 Sep 27. doi: 10.1002/ijc.31078.
    >> Share

  374. THAPA B, Bahadur Kc R, Uludag H
    Novel Targets for Sensitizing Breast Cancer Cells to TRAIL-Induced Apoptosis with siRNA Delivery.
    Int J Cancer. 2017 Sep 27. doi: 10.1002/ijc.31079.
    >> Share

  375. GABELLINI C, Gomez-Abenza E, Ibanez-Molero S, Tupone MG, et al
    Interleukin 8 mediates bcl-xL-induced enhancement of human melanoma cell dissemination and angiogenesis in a zebrafish xenograft model.
    Int J Cancer. 2017 Sep 26. doi: 10.1002/ijc.31075.
    >> Share

  376. WILKE CM, Hess J, Klymenko SV, Chumak VV, et al
    Expression of miRNA-26b-5p and its target TRPS1 is associated with radiation exposure in post-Chernobyl breast cancer.
    Int J Cancer. 2017 Sep 25. doi: 10.1002/ijc.31072.
    >> Share

  377. KORCH C, Hall EM, Dirks WG, Ewing M, et al
    Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line.
    Int J Cancer. 2017 Sep 22. doi: 10.1002/ijc.31067.
    >> Share

  378. KIMBUNG S, Markholm I, Bjohle J, Lekberg T, et al
    Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab: results from the phase 2 PROMIX trial.
    Int J Cancer. 2017 Sep 22. doi: 10.1002/ijc.31070.
    >> Share

  379. WANG S, Huo D, Kupfer S, Alleyne D, et al
    Genetic variation in the Vitamin D related pathway and breast cancer risk in women of African ancestry in the Root Consortium.
    Int J Cancer. 2017 Sep 10. doi: 10.1002/ijc.31038.
    >> Share

  380. LAGENDIJK M, van Maaren MC, Saadatmand S, Strobbe LJ, et al
    Breast conserving therapy and mastectomy revisited: Breast cancer-specific survival and the influence of prognostic factors in 129,692 patients.
    Int J Cancer. 2017 Sep 7. doi: 10.1002/ijc.31034.
    >> Share

    August 2017
  381. BERTRAND KA, Gerlovin H, Bethea TN, Palmer JR, et al
    Pubertal growth and adult height in relation to breast cancer risk in African American women.
    Int J Cancer. 2017 Aug 28. doi: 10.1002/ijc.31019.
    >> Share

  382. WU AH, Vigen C, Butler LM, Tseng CC, et al
    Metabolic conditions and breast cancer risk among Los Angeles County Filipina Americans compared with Chinese and Japanese Americans.
    Int J Cancer. 2017 Aug 26. doi: 10.1002/ijc.31018.
    >> Share

  383. CESPEDES FELICIANO EM, Prentice RL, Aragaki AK, Neuhouser ML, et al
    Methodological Considerations for Disentangling a Risk Factor's Influence on Disease Incidence versus Post-Diagnosis Survival: The Example of Obesity and Breast and Colorectal Cancer Mortality in the Women's Health Initiative.
    Int J Cancer. 2017 Aug 18. doi: 10.1002/ijc.30931.
    >> Share

  384. ZHENG G, Yu H, Hemminki A, Forsti A, et al
    Familial associations of female breast cancer with other cancers.
    Int J Cancer. 2017 Aug 12. doi: 10.1002/ijc.30927.
    >> Share

  385. KVALE R, Myklebust TA, Engholm G, Heinavaara S, et al
    Prostate and breast cancer in four Nordic countries: A comparison of incidence and mortality trends across countries and age groups 1975-2013.
    Int J Cancer. 2017 Aug 10. doi: 10.1002/ijc.30924.
    >> Share

  386. WHITE AJ, Weinberg CR, Park YM, D'Aloisio AA, et al
    Sleep characteristics, light at night and breast cancer risk in a prospective cohort.
    Int J Cancer. 2017 Aug 9. doi: 10.1002/ijc.30920.
    >> Share

    July 2017
  387. NILENDU P, Kumar A, Kumar A, Pal JK, et al
    Breast cancer stem cells as last soldiers eluding therapeutic burn: A hard nut to crack.
    Int J Cancer. 2017 Jul 19. doi: 10.1002/ijc.30898.
    >> Share

  388. SANDSVEDEN M, Manjer J
    Selenium and breast cancer risk: A prospective nested case-control study on serum selenium levels, smoking habits and overweight.
    Int J Cancer. 2017 Jul 6. doi: 10.1002/ijc.30875.
    >> Share

  389. SANKATSING VDV, van Ravesteyn NT, Heijnsdijk EAM, de Koning HJ, et al
    Reply to Letter to Editor: 'Questionable method for estimating the influence of mammography screening on breast cancer mortality in the Netherlands.'
    Int J Cancer. 2017 Jul 6. doi: 10.1002/ijc.30873.
    >> Share

  390. AUTIER P, Boniol M
    Questionable method for estimating the influence of mammography screening on breast cancer mortality in the Netherlands.
    Int J Cancer. 2017 Jul 6. doi: 10.1002/ijc.30874.
    >> Share

  391. SCHIROSI L, De Summa S, Tommasi S, Paradiso A, et al
    VEGF and TWIST1 in a 16-biomarker immunoprofile useful for prognosis of breast cancer patients.
    Int J Cancer. 2017 Jul 5. doi: 10.1002/ijc.30868.
    >> Share

  392. BARRDAHL M, Rudolph A, Hopper JL, Southey MC, et al
    Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30859.
    >> Share

    June 2017
  393. FELLER A, Schmidlin K, Bordoni A, Bouchardy C, et al
    Socioeconomic and demographic disparities in breast cancer stage at presentation and survival: A Swiss population-based study.
    Int J Cancer. 2017 Jun 28. doi: 10.1002/ijc.30856.
    >> Share

  394. ALMOZYAN S, Colak D, Mansour F, Alaiya A, et al
    PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation.
    Int J Cancer. 2017 Jun 14. doi: 10.1002/ijc.30834.
    >> Share

    May 2017
  395. KNIGHT JA, Fan J, Malone KE, John EM, et al
    Alcohol consumption and cigarette smoking in combination: a predictor of contralateral breast cancer risk in the WECARE Study.
    Int J Cancer. 2017 May 19. doi: 10.1002/ijc.30791.
    >> Share

  396. VAN DEN ENDE C, Oordt-Speets AM, Vroling H, van Agt HME, et al
    Benefits and harms of breast cancer screening with mammography in women aged 40-49 years: A systematic review.
    Int J Cancer. 2017 May 19. doi: 10.1002/ijc.30794.
    >> Share

  397. LOLAS HAMAMEH S, Renbaum P, Kamal L, Dweik D, et al
    Genomic analysis of inherited breast cancer among Palestinian women: Genetic heterogeneity and a founder mutation in TP53.
    Int J Cancer. 2017 May 9. doi: 10.1002/ijc.30771.
    >> Share

  398. BEAU AB, Lynge E, Njor SH, Vejborg I, et al
    Benefit-to-harm ratio of the Danish breast cancer screening programme.
    Int J Cancer. 2017 May 3. doi: 10.1002/ijc.30758.
    >> Share

    April 2017
  399. SANKATSING VDV, van Ravesteyn NT, Heijnsdijk EAM, Looman CWN, et al
    The effect of population-based mammography screening in Dutch municipalities on breast cancer mortality: 20 years of follow-up.
    Int J Cancer. 2017 Apr 29. doi: 10.1002/ijc.30754.
    >> Share

  400. NARKHEDE AA, Shevde LA, Rao SS
    Biomimetic strategies to recapitulate organ specific microenvironments for studying breast cancer metastasis.
    Int J Cancer. 2017 Apr 25. doi: 10.1002/ijc.30748.
    >> Share

    March 2017
  401. MARTINEZ VG, Crown J, Porter RK, O'Driscoll L, et al
    Neuromedin U alters bioenergetics and expands the cancer stem cell phenotype in HER2-positive breast cancer.
    Int J Cancer. 2017 Mar 24. doi: 10.1002/ijc.30705.
    >> Share

  402. YANG Z, Hackshaw A, Feng Q, Fu X, et al
    Comparison of gefitinib, erlotinib and afatinib in non-small cell lung cancer: A meta-analysis.
    Int J Cancer. 2017 Mar 14. doi: 10.1002/ijc.30691.
    >> Share

  403. BRINTON LA, Awuah B, Clegg-Lamptey JN, Wiafe-Addai B, et al
    Design considerations for identifying breast cancer risk factors in a population-based study in Africa.
    Int J Cancer. 2017 Mar 13. doi: 10.1002/ijc.30688.
    >> Share

  404. PARK YM, White AJ, Nichols HB, O'Brien KM, et al
    The association between metabolic health, obesity phenotype and the risk of breast cancer.
    Int J Cancer. 2017 Mar 7. doi: 10.1002/ijc.30684.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016